San Francisco County, Calif., funds by Health and Human Services, Department of
Listing $240,363,551.98 in stimulus funds from Health and Human Services, Department of for San Francisco
Note: For some programs where states do not report where money will be distributed across the state, we do not have the allocation for individual counties. Those programs include: Medicaid, unemployment benefits and food stamps. Those amounts are included in the totals for where the state agency receiving that money is located.
Amount refers to both the amount of stimulus funding going toward the project and the face value of the loan.
| Recipient | Amount | Description | Federal Dept./Agency | Date |
|---|---|---|---|---|
| SAN FRANCISCO UNIFIED SCHOOL DISTRICT | $20,000,000 |
ARRA Child Care and Development Block Grant Title: ARRA Supplemental Funding for Child Care and Development Fund (CCDF); Description: Provide child care financial assistance to low-income working families and fund activities to improve the quality of child care.
This spending item is part of a $220,273,864 allocation.
See details
|
Administration for Children and Families | 4/09/2009 |
| CITY & COUNTY OF SAN FRANCISCO | $9,508,907 | National Center for Research Resources, Recovery Act Construction Support The award provides funding for the expansion & renovation of 17,417 sq ft of space at 25 Van Ness Avenue. The project will expand, renovate, & reorganize the three (3) Research units of the San Francisco Department of Public H Health to maximize efficiency... Show more | National Institutes of Health | 3/04/2010 |
| CITY & COUNTY OF SAN FRANCISCO | $9,508,907 | National Center for Research Resources, Recovery Act Construction Support The award provides funding for the expansion & renovation of 17,417 sq ft of space at 25 Van Ness Avenue. The project will expand, renovate, & reorganize the three (3) Research units of the San Francisco Department of Public H Health to maximize efficiency... Show more | National Institutes of Health | 3/04/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $7,830,280 |
Trans-NIH Recovery Act Research Support The goal of this 'Grand Opportunities' project is to create a unique and comprehensive population-based resource for research into the genetic and environmental basis of common age-related diseases and their treatment, and factors influencing healthy agin
This spending item is part of a $24,846,000 allocation.
See details
|
National Institutes of Health | 9/29/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $6,656,732 |
Recovery Act Comparative Effectiveness Research - AHRQ The STONE study, a multi-center randomized controlled trial (RCT), is a comparative effectiveness trial of three different imaging strategies in patients with suspected urolithiasis (kidney stones), seen in the Emergency Department. The study fofocuses on ... Show more
This spending item is part of a $9,154,210 allocation.
See details
|
Agency for Healthcare Research and Quality | 9/28/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $4,060,337 | Trans-NIH Recovery Act Research Support Our aims are to examime 1 Genome-wide single nucleotide polymorphism analysis and 2 Fat, metabolism and liver fibrosis. Purpose: Grant 1 is to facilitate 35 genetic studies in the Womens HIV Study (WIHS) and to test human genetics hypotheses by improving | National Institutes of Health | 6/28/2010 |
| LUMETRA HEALTHCARE SOLUTIONS | $3,674,880 |
ARRA - Health Information Technology Extension Program In partnership with the California Primary Care Association (CPCA), the California Medical Association (CMA), and the California Association of Public Hospitals and Health Systems (CAPH), the California Regional Extension Center, doing business a as the Cal... Show more
This spending item is part of a $19,228,626 allocation.
See details
|
Health and Human Services, Department of | 2/08/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $3,373,920 | Trans-NIH Recovery Act Research Support To develop and implement innovative approaches to translate existing data on the health benefits of HIV prevention and treatment interventions into an accurate and transparent empirical basis for global health HIV policies and programs. | National Institutes of Health | 9/29/2010 |
| CALIFORNIA HEALTH CARE SAFETY NET INSTITUTE | $3,048,480 |
ARRA - Health Information Technology Extension Program In partnership with the California Primary Care Association (CPCA), the California Medical Association (CMA), and the California Association of Public Hospitals and Health Systems (CAPH), the California Regional Extension Center, doing business a as the Cal... Show more
This spending item is part of a $19,228,626 allocation.
See details
|
Health and Human Services, Department of | 2/08/2010 |
| BRAIN PLASTICITY INC. | $2,969,780 | Trans-NIH Recovery Act Research Support People with schizophrenia have significant challenges functioning in society, including finding and maintaining employment, making friends, and living independently. These challenges place a tremendous burden on people with schizophrenia, as well as their | National Institutes of Health | 7/27/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $2,696,666 |
Trans-NIH Recovery Act Research Support Grant name: POINT. The purpose of the Platelet-Oriented Inhibition in New TIA and minor ischemic stroke (POINT) Trial is to determine the safety and effectiveness of the combination of low-dose aspirin and a medication called clopidogrel (also known by th
This spending item is part of a $12,424,539 allocation.
See details
|
National Institutes of Health | 9/30/2009 |
| PUBLIC HEALTH FOUNDATION ENTERPRISES, INC. | $2,521,856 | Trans-NIH Recovery Act Research Support The San Francisco Vaccine and Prevention Unit (SFVPU) provides scientific leadership, capacity to recruit study volunteers into vaccine and non-vaccine prevention trials, innovative methods for community engagement in research, and mentorship of junior in | National Institutes of Health | 8/28/2009 |
| COMMUNITY ACCESS HCCN, LLC | $2,519,875 | ARRA Health Center Integrated Services Development Initiative[g1] EHR for Community Access HCCN aims to fully implement electronic health records (EHR) at Community Access HCCNG??s member clinics by May 2012 to improve quality of care, effectively engage in population health management, and simultaneneously address the fe... Show more | Health Resources and Services Administration | 6/01/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $2,299,500 | Trans-NIH Recovery Act Research Support 3T/DNP grant: The objective of this proposal is to purchase a new high-performance dynamic nuclear polarizer (DNP) and specialized components for acquiring cutting edge anatomic, physiological and metabolic imaging data for evaluating novel therapeutics. | National Institutes of Health | 6/03/2010 |
| NORTHERN CALIFORNIA INSTITUTE FOR RESEARCH AND EDUCATION, INC. | $2,092,811 |
Trans-NIH Recovery Act Research Support Our goal is to determine the clinical, cognitive, imaging, genetic, and biochemical biomarker characteristics of the early (pre-dementia) stages of Alzheimer's disease (AD). The project builds on the NIA-funded AD Neuroimaging Initiative (ADNI1) and serve
This spending item is part of a $23,822,294 allocation.
See details
|
National Institutes of Health | 9/24/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $2,072,331 |
Trans-NIH Recovery Act Research Support Develop and test virus constructs for reliable and selective expression of light-activated ion channels across species; develop and test technology for the precise control of in-vivo activation of these channels in behaving animals.
This spending item is part of a $2,999,576 allocation.
See details
|
National Institutes of Health | 9/28/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $2,036,865 |
Trans-NIH Recovery Act Research Support Parkinson's disease (PD) is a neurodegenerative disorder characterized by death of substantia nigra (SN) dopamine neurons (DANs), dopamine deficiency within the striatum and a clinical movement disorder. Most PD is sporadic/idiopathic that may arise from
This spending item is part of a $3,907,801 allocation.
See details
|
National Institutes of Health | 9/29/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $1,914,198 |
Trans-NIH Recovery Act Research Support Advances in basic science research over the past 20 years have created new opportunities for targeted therapies for TBI, but such advances have failed to translate into successful clinical trials or treatments. Improving the quality of healthcare delivery
This spending item is part of a $4,131,403 allocation.
See details
|
National Institutes of Health | 9/28/2009 |
| GLOBAL VIRAL FORECASTING, INC. | $1,813,010 | Trans-NIH Recovery Act Research Support This proposal seeks to apply an innovative, streamlined approach to facilitate the discovery of previously unidentified viral signatures in the several major human cancers from skin, kidney, brain, colon and the pancreas. This pilot effort will form the b | National Institutes of Health | 9/28/2009 |
| HEALTH 2.0, LLC | $1,748,520 |
ONC Investing in Innovation i2 Support
This spending item is part of a $4,253,259 allocation.
See details
|
Program Support Center | 3/18/2011 |
| J.DAVID GLADSTONE INSTITUTES, THE | $1,728,000 | Trans-NIH Recovery Act Research Support The Gladstone Institute of Neurological Disease (GIND) at he University of California, San Francisco (UCSF) uses an interdisciplinary teann approach to the investigation of neurodegenerative disorders. Alzheimer's disease (AD) is the main cause of aging-r | National Institutes of Health | 9/25/2009 |
| NORTH EAST MEDICAL SERVICES | $1,605,900 | ARRA Health Center Integrated Services Development Initiative[g1] North East Medical Services (NEMS) will use Capital Improvement Program (CIP) funds under the American Recovery and Reinvestment Act (ARRA) to work on three new projects: Project #69407-01) Expand ancillary services such as health eduducation, pharmacy, Me... Show more | Health Resources and Services Administration | 6/25/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $1,521,689 |
Trans-NIH Recovery Act Research Support ZAP-70, a cytoplasmic enzyme involved in intracellular signaling, plays a critical role in T cells, as is underscored by the immunodeficiencies that result from zap70 gene inactivation. Thus, ZAP-70 is an attractive therapeutic target in T cell mediated a
This spending item is part of a $1,812,291 allocation.
See details
|
National Institutes of Health | 9/25/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $1,506,048 |
After responding to a Request for Proposal issued by the National Institutes of Health entitled Recovery Act Contract Action: Providing Radiologic Outcomes for the Osteoarthritis Initiative, the Osteoarthritis Initiative (OAI) study received funding from
This spending item is part of a $1,932,637 allocation.
See details
|
National Institutes of Health | 3/29/2010 |
| J.DAVID GLADSTONE INSTITUTES, THE | $1,465,000 | Trans-NIH Recovery Act Research Support 'Developing Transmissable Antivirals by Exploiting Gene-Expression Circuitry' Emerging and established viral diseases take an enormous toll on human health. Current treatment approaches are unlikely to halt epidemic spread of many viruses, notably HIV-1 | National Institutes of Health | 12/09/2011 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $1,454,073 | Trans-NIH Recovery Act Research Support Symptom Mgmt. Faculty Scholars Porgram is developing 6 new Assistant Professors who are receiving focused training from senior faculty, to become skilled, independant researchers with grantsmanship skills, who can disseminate findings in journals, and bec | National Institutes of Health | 9/24/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $1,406,387 | Trans-NIH Recovery Act Research Support Late Parenting & Biotechnology: Rethinking Age, Gender, Family, & the Life Course. Late parenthood is a recent phenomenon which reflects both a shift in the reproductive pattern of the baby boom generation and the development and proliferation of advance | National Institutes of Health | 8/24/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $1,389,712 | Trans-NIH Recovery Act Research Support The goals of this award New Faculty Development for Research to Reduce Oral Heal (NIH/NIDCR P30 DE020752) are to appoint independent, tenure-track equivalent research intensive Assistant Professors at the UCSF School of Dentistry along with Research Assis | National Institutes of Health | 9/17/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $1,385,353 |
The Cancer Knowledge Cloud will connect and share information generated through NCI genomic atlas projects, the caHUB tissue acquisition network, the NCI functional Biology Consortium, NCI patient Characterization Center, the NCI pre-clinical Development
This spending item is part of a $103,000,000 allocation.
See details
|
National Institutes of Health | 11/23/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $1,376,805 | Recovery Act Comparative Effectiveness Research - AHRQ Last year we accomplished the following on the project: 1) Completed enrollment in the first (control arm) of the intervention, with a total of 55 persons with RA enrolled, of whom 19 (35%) speak English as their first language, 22 (40%) speak S Spanish, a... Show more | Agency for Healthcare Research and Quality | 8/12/2010 |
| ECONOMIC OPPORTUNITY COUNCIL OF SAN FRANCISCO, INC | $1,373,146 |
ARRA - Community Services Block Grant The Community Services Block Grant (CSBG) American Recovery and Reinvestment Act (ARRA) funding appropriated $89 million to support the activities provided by 60 California CSBG eligible entities. The CSBG eligible entities are comprised of local governme
This spending item is part of a $89,150,062 allocation.
See details
|
Administration for Children and Families | 4/10/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $1,368,750 | Trans-NIH Recovery Act Research Support The ExAblate 2100 system had been purchased and delivered. Also, the system has been installed and tested. The requested instrument is an MR-guided Focused UltraSound (MRgFUS) system for use with a newly installed state-of-the-art 3T MRI scanner at the Un | National Institutes of Health | 7/08/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $1,260,717 | Trans-NIH Recovery Act Research Support Improving Self-Reports About High Risk Sexual Behavior. Research findings of sex surveys provide abundant empirical evidence that the reliability and validity of self-reported sexual behavior is a major problem, particularly when assessing behavior among | National Institutes of Health | 8/24/2009 |
| BLOOD SYSTEMS, INC. | $1,248,658 |
Trans-NIH Recovery Act Research Support There is increasing concern over the impact of global arbovirus epidemics on blood safety. This research program will address the blood safety implications of Dengue and WNV, two of the most important arboviruses, and further guide development of rationa
This spending item is part of a $2,118,432 allocation.
See details
|
National Institutes of Health | 9/28/2009 |
| VAXART, INC | $1,246,796 | Trans-NIH Recovery Act Research Support 'Vaxart is developing a new vaccine to prevent infection by Venezuelan Equine Encephalitis (VEE), a pathogen that can infect laboratory workers and has biowarfare potential. Because of the dangers involved with previous vaccines, we propose to develop a s | National Institutes of Health | 9/11/2009 |
| VAXART, INC | $1,246,796 | Trans-NIH Recovery Act Research Support Vaxart is developing a new vaccine to prevent infection by Venezuelan Equine Encephalitis (VEE), a pathogen that can infect laboratory workers and has biowarfare potential. Because of the dangers involved with previous vaccines, we propose to develop a sa | National Institutes of Health | 9/12/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $1,177,239 |
Recovery Act Comparative Effectiveness Research - AHRQ Prostate cancer is the most common solid tumor and the second leading cause of cancer death among American men. While surgery, radiation and observation have all been deemed appropriate for newly diagnosed men, tremendous uncertainty remains regagarding the... Show more
This spending item is part of a $7,572,695 allocation.
See details
|
Agency for Healthcare Research and Quality | 8/12/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $1,144,320 |
Recovery Act Comparative Effectiveness Research - AHRQ The G?Variations in Care: Comparing Heart Failure Care Transition Intervention EffectsG? is a comparative effectiveness project that examines approaches to improve variation in resource use and mortality among the five University of California MeMedical Cen... Show more
This spending item is part of a $9,898,332 allocation.
See details
|
Agency for Healthcare Research and Quality | 9/28/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $1,103,695 | Trans-NIH Recovery Act Research Support Molecular Genetics of HLA and Disease: Our overall objective is to advance the understanding of autoimmunity through genetic analysis of the polygenic Human Leukocyte Antigen (HLA) locus, the strongest genetic factor identified as influencing risk for aut | National Institutes of Health | 9/11/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $1,081,482 | Trans-NIH Recovery Act Research Support Grant Name: Mechanism of Pseudomonas-mediated epithelial cell damage Pseudomonas aeruginosa (PA) is one of the most virulent opportunistic pathogens of man. The morbidity of PA infections results from the ability of the bacterium to colonize previously in | National Institutes of Health | 5/21/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $1,072,066 |
Trans-NIH Recovery Act Research Support The Impact of Early Antiretroviral Therapy in HIV Persistence grant aims to determine the effect of early versus delayed HAART on viral persistence, and to determine the association between high-through put measures of low level viral load and amount of r
This spending item is part of a $1,408,606 allocation.
See details
|
National Institutes of Health | 9/25/2009 |
| SCIENTIFIC ANALYSIS CORPORATION | $1,062,692 | Trans-NIH Recovery Act Research Support A Qualitative Study of Women Prescription Drug Sellers This Qualitative research project will provide much needed empirical information about women who sell prescription drugs and their unique experiences in order to design more appropriate and effective | National Institutes of Health | 7/16/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $1,018,918 |
Trans-NIH Recovery Act Research Support The goal of this project is to develop new, improved metabolic MRI imaging methods and translate them to be applicable for future human patient studies. This project is based on a recently invented method for providing real time metabolic imaging. The met
This spending item is part of a $1,221,350 allocation.
See details
|
National Institutes of Health | 9/22/2009 |
| LUMETRA HEALTHCARE SOLUTIONS | $1,006,500 |
ARRA - Health Information Technology Extension Program Technical assistance services for primary care health providers to support electronic health record adoption. In partnership with the California Primary Care Association (CPCA), the California Medical Association (CMA), and the California Assosociation o... Show more
This spending item is part of a $15,760,570 allocation.
See details
|
Health and Human Services, Department of | 2/08/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $1,005,920 | Trans-NIH Recovery Act Research Support Waters Synapt G2 HDMS enables structural characterization of biological molecules whose malfunction triggers and/or affects disease processes. Synapt G2 will support studies on cancer, reproductive and endocrine disorders and bacterial infections. | National Institutes of Health | 5/27/2010 |
| COMMUNITY INITIATIVES | $1,000,000 | ARRA Strengthening Communities Fund ARRA Strengthening Communities Fund Nonprofits Capacity Building Program: This award is made to organizations with experience in capacity building and requires that they act as a lead organization for the project in a geographic service area which is at o | Administration for Children and Families | 9/17/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $999,999 | Trans-NIH Recovery Act Research Support Grant Name: Determinants of Participation in an Anal Cancer Prevention Trial (IMPACT) The incidence of anal cancer among people with HIV is higher than cervical cancer was before routine cervical cytology screening was introduced, but unlike cervical can | National Institutes of Health | 9/29/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $998,170 | Trans-NIH Recovery Act Research Support The 'Adherence, Improvement & Measurement (AIM) System' grant works to develop an application to promote medication adherence using wireless technology, specifically examining adherence for antiretroviral medications and common medical and health conditio | National Institutes of Health | 9/24/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $996,825 | Trans-NIH Recovery Act Research Support The title of grant # RC1 HL099820 is Novel reagents for alveolar type I and type II cells. The goals of the project are twofold. 1) To generate transgenic animals that can be used for conditional knockouts specifically in alveolar epithelial type I or ty | National Institutes of Health | 9/18/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $994,917 | Trans-NIH Recovery Act Research Support In 2005, nearly 40% of the US population had diabetes or pre-diabetes. Diabetes is caused by insufficient insulin production by the pancreatic beta cell. In this grant, we propose to identify novel genes that are important for insulin production. We hope | National Institutes of Health | 9/21/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $989,235 | Trans-NIH Recovery Act Research Support Grant name: 'CFTR Inhibitors for therapy of polycistic kidney disease'. The goal of this grant is to select the best candidate molecule(s) for therapy of autosomal dominant polycystic kidney disease (AKPKD) to move forward in pre-clinical development. In | National Institutes of Health | 9/25/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $986,388 | Trans-NIH Recovery Act Research Support Name of Project: Restraint-based modeling of macro- and supramolecular structure: tools and resources for launching calculations, monitoring progress, and viewing and disseminating results. Goals of project: Enhance the capabilities of the UCSF Chimera | National Institutes of Health | 9/15/2009 |
| J.DAVID GLADSTONE INSTITUTES, THE | $955,000 | Trans-NIH Recovery Act Research Support Transcription factors are key regulators of several aspects of organogenesis, and in the heart, several important DNA-binding transcription factors are powerful regulators of cardiac cell fate and organogenesis. Less well studied are the roles played by t | National Institutes of Health | 6/01/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $954,923 | Trans-NIH Recovery Act Research Support P30 RFA is to support the hiring of newly recruited faculty to develop research projects within the context of MQIR Core Center. We enhance this core with two key faculty recruitments. 1) A faculty position focused on developing imaging techniques, utiliz | National Institutes of Health | 9/29/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $953,091 | Trans-NIH Recovery Act Research Support R01 HL090662-01A2 (Role of Squamous Metaplasia in Small Airways Disease in COPD): Chronic obstructive pulmonary disease is a devastating disease, which is a major cause of mortality and morbidity worldwide. Currently, there are no effective therapies to t | National Institutes of Health | 8/31/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $951,502 | Trans-NIH Recovery Act Research Support We will determine if medial ganglionic eminence (MGE) progenitors, transplanted into the murine spinal cord at a level caudal to the site of spinal cord injury (SCI), will assume a mature inhibitory neuronal phenotype, integrate into local circuitry, and | National Institutes of Health | 9/24/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $944,072 | Trans-NIH Recovery Act Research Support To examine and compare the feasibility, acceptability, and impact of conducting SBIRT through (1) a self-administered, web-based Personal Health Record compared to (2) a provider-administered protocol during clinic appointments. | National Institutes of Health | 9/25/2009 |
| SCIENTIFIC ANALYSIS CORPORATION | $924,705 |
Trans-NIH Recovery Act Research Support Meta-Analysis Systematic and Design Errors: Alcohol Use and Disease Outcomes The meta-analysis of relevant epidemiological studies evaluating alcohol consumption and multiple disease outcomes should inform clinicians and public health policy by more care
This spending item is part of a $974,701 allocation.
See details
|
National Institutes of Health | 9/22/2009 |
| GLOBAL VIRAL FORECASTING, INC. | $921,118 |
Trans-NIH Recovery Act Research Support This proposal seeks to apply an innovative, streamlined approach to facilitate the discovery of previously unidentified viral signatures in the several major human cancers from skin, kidney, brain, colon,and the pancreas. This pilot effort will form the b
This spending item is part of a $1,813,010 allocation.
See details
|
National Institutes of Health | 9/28/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $897,004 |
Trans-NIH Recovery Act Research Support The purpose of the Comparative Effectiveness Large Dataset Analysis Core is to foster efficient and sophisticated use of very large health data sets: 1. Build the necessary data repository infrastructure that will enable CTSI-UCSF and its collaborating CT
This spending item is part of a $986,522 allocation.
See details
|
National Institutes of Health | 9/26/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $889,321 | Trans-NIH Recovery Act Research Support This project aims to apply the discovery that an immune molecule, tumor necrosis factor (TNF), changes the excitability of neurons to the transmitter glutamate, increasing cell death after spinal cord injury. Drugs that block TNF will be used to reduce se | National Institutes of Health | 2/26/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $881,422 | Trans-NIH Recovery Act Research Support Study of MMP-9, which governs damaging and reparative processes in injured spinal cords. A long-term goal is to develop targeted therapeutic interventions to block MMP-mediated adverse events without compromising those functions that facilitate recovery. | National Institutes of Health | 7/29/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $862,146 |
Trans-NIH Recovery Act Research Support The grant name is UCSF Living Heart Resource. Establish the infrastructure to obtain, in a standardized manner, diseased and healthy human cardiac tissue obtained at surgery for immediate electromechanical studies to further the fundamental understanding
This spending item is part of a $999,903 allocation.
See details
|
National Institutes of Health | 9/21/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $861,672 | Trans-NIH Recovery Act Research Support In this Supplement we will increase the tempo of our research by hiring new personnel and purchasing new equipment. Project 1 will accelerate the tempo of analyzing new molecules in epithelial wound healing by hiring a new postdoctoral fellow. his supple | National Institutes of Health | 9/01/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $849,750 | Trans-NIH Recovery Act Research Support Demyelinating and dysmyelinating disorders include a significant number of degenerative conditions in human including Multiple Sclerosis. However, our knowledge of these processes is still limited and effective treatments for most of the demyelinating/dys | National Institutes of Health | 7/20/2009 |
| SMITH-KETTLEWELL EYE RESEARCH INSTITUTE, THE | $840,322 | Trans-NIH Recovery Act Research Support We propose to develop and evaluate a cell-phone based system to enable blind and visually impaired individuals to find and read street signs and other signs relevant to wayfinding. Using the built-in camera and computing power of a standard cell phone, t | National Institutes of Health | 8/11/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $840,308 | Trans-NIH Recovery Act Research Support 80 individuals have been recruited, 40 with diabetes & 40 controls (each group consisting of 20 with and 20 without fragility fractures). Hr-pQCT, QCT, DXA and MR spectroscopy of the spine have been performed to assess cortical and trabecular bone micro-a | National Institutes of Health | 9/29/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $833,493 | Trans-NIH Recovery Act Research Support The overall goal of this project is to use advanced magnetic resonance imaging (MRI) to understand mechanisms leading to neurodevelopmental impairment in critically ill newborns with congenital heart disease (CHD). Research studies have determined that i | National Institutes of Health | 9/21/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $833,162 | Trans-NIH Recovery Act Research Support As planned (and described in the recent progress report for our parent grant), we batched specimens from our first three cohorts for our initial set of cell aging work. The Core Immunology Lab is nearly done with phenotyping, sorting and staining PBMC fro | National Institutes of Health | 9/14/2009 |
| HEBREW HOME FOR AGED DISABLED | $831,981 | Trans-NIH Recovery Act Research Support The overall goal is to improve the use of medications for older people with multiple medical disorders. Our first step will be to identify the prevalence, type and severity of prescribing problems in older people with defined patterns of multiple co-morbi | National Institutes of Health | 9/24/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $828,922 | Trans-NIH Recovery Act Research Support This supplement funded studies centered on a poorly understood fundamental aspect of P450 regualation and turnover, focusing on two P450s that significantly contributed to clincally relevant drug metabolism. | National Institutes of Health | 6/11/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $800,838 | Trans-NIH Recovery Act Research Support Project Title: A Technological Platform for the Identification of Serine Proteases in Cancer; Our goal in this project is to develop highly sensitive methods to monitor the activity of a class of enzymes known as proteases that have been implicated in ca | National Institutes of Health | 7/17/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $780,862 |
Trans-NIH Recovery Act Research Support The goal of this grant is to develop and validate a Virochip-based diagnostic assay for category A-C viral pathogens (biothreat detection-micorarray) that is rapid, sensitive/specific, portable and cost-effective, yet capable of simultaneously detecting a
This spending item is part of a $888,279 allocation.
See details
|
National Institutes of Health | 8/09/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $776,222 | Trans-NIH Recovery Act Research Support Nonalchoholic Steatohepatitis Clinical Research Network: NASH. The purpose of the requested supplement is to fund the Cytokine Multiplex Assay Substudy of the nonalcoholic steatohepatitis (NASH) clinical research network (CRN), that proposes to quantify p | National Institutes of Health | 2/17/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $774,862 | Trans-NIH Recovery Act Research Support R01NS055915-01A2. We have quantified the expression of the basal lamina proteins collagen IV and laminin after acute neonatal and adult stroke using a 3D reconstruction system. We also conducted additional Western Blot experiments to quantify the role of | National Institutes of Health | 8/04/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $772,500 | Trans-NIH Recovery Act Research Support We have successfully identified and recruited junior faculty member of the caliber of Xiaokun Shu to be part of the Chemical Biology group. Currently, Dr. Shu has 1 person in his lab, (Post Doc) . Furthermore, Dr. Shu has begun setting up his lab. The lon | National Institutes of Health | 9/30/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $765,887 | Trans-NIH Recovery Act Research Support This ARRA R01 project, entitled Specification and development of ciliary body and anterior eye epithelium, seeks to provide better basic understanding of early eye development, particularly of the anterior portion of the eye, and to link genetic informati | National Institutes of Health | 6/19/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $765,388 | Trans-NIH Recovery Act Research Support The title of the project is Resolving microRNA Targets. The nature of small RNA biology is not well understood, and there is a need to develop additional tools to interrogate the factors involved. MAJOR GOAL - The goal of this proposal is to identify mi | National Institutes of Health | 6/01/2009 |
| J.DAVID GLADSTONE INSTITUTES, THE | $764,000 |
Trans-NIH Recovery Act Research Support This consortium aims to capitalize on an unprecedented 'grand' opportunity to develop a novel and powerful model of Huntington's disease (HD), a fatal neurodegenerative condition with no current treatment. Skin cells from patients with HD can be reprogram
This spending item is part of a $3,776,244 allocation.
See details
|
National Institutes of Health | 9/30/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $735,600 | Trans-NIH Recovery Act Research Support This grant provided the research resources for a study of basic mechanisms of optic nerve damage in glaucoma. | National Institutes of Health | 6/05/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $729,636 | Trans-NIH Recovery Act Research Support Study will gain mechanistic insights on unique immunological properties of HIV positive patients, which will increase the fundamental understanding of immune regulation/HIV infection and provide guidance in designing treatment regimens. | National Institutes of Health | 8/14/2009 |
| NORTH EAST MEDICAL SERVICES | $728,697 | ARRA Health Center Integrated Services Development Initiative[g1] North East Medical Services (NEMS) has used Increased Demand for Services (IDS) funds under the American Recovery and Reinvestment Act (ARRA) to hire new health care staff for our locations in San Francisco and San Jose, California. ThThese additional staff... Show more | Health Resources and Services Administration | 3/27/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $724,938 |
Trans-NIH Recovery Act Research Support The combined threat of cardiovascular disease (CVD) and obesity is arguably the worst major health problem affecting the western world. While there has been progress in reducing CVD mortality, death rates remain unacceptably high. Current approaches to tr
This spending item is part of a $2,921,456 allocation.
See details
|
National Institutes of Health | 9/30/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $718,000 | Trans-NIH Recovery Act Research Support Grant Name: Selective Ablation of Dental Caries and Composites. The overall objective of this research is to increase our fundamental understanding of the interaction of high intensity laser radiation with dental hard tissues and apply that knowledge to d | National Institutes of Health | 9/01/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $712,293 | Trans-NIH Recovery Act Research Support Project Title: Manipulation of Macrophage Responses by M. tuberculosis. This grant provided funding for studies on the molecular basis of tuberculosis pathogenesis to determine the pathogen and host factors responsible for innate immune signaling during | National Institutes of Health | 9/01/2009 |
| SAN FRANCISCO COMMUNITY CLINIC CONSORTIUM | $702,935 | ARRA Health Center Integrated Services Development Initiative[g1] SFCCC Capital Improvement Projects for Health Care for the Homeless Clinics. SFCCC and its partner clinics have make capital improvements to eight service sites. One project was a new citywide fiber cable network for transmitting prorotected health inform... Show more | Health Resources and Services Administration | 6/25/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $700,228 |
Trans-NIH Recovery Act Research Support Title: Imaging and Tissue Biomarkers in the Treatment of Brain Tumors. The aim of the Program Project is focused on the development of physiologic neuro-imaging methodologies and tissue biomarkers for the management of brain tumor patients with the ultim
This spending item is part of a $812,687 allocation.
See details
|
National Institutes of Health | 9/01/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $683,617 | Trans-NIH Recovery Act Research Support This grant (5R01CA134622) funds experiments techniques using ground-breaking microscopy techniques to directly examine immune cells within breast tumors. The study examines T cells of the immune system and is examining, at a very fine detail, how the imm | National Institutes of Health | 7/17/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $677,883 | Trans-NIH Recovery Act Research Support The grant name is Mechanisms of Initiation and Persistence of Allergic Asthma. This award facilitates studies of the mechanisms of asthma and allergies. The goals of the project are to enhance the processing of human and mouse airway tissue, to develop ef | National Institutes of Health | 8/14/2009 |
| MISSION AREA HEALTH ASSOCIATES | $677,770 | ARRA Health Center Integrated Services Development Initiative[g1] ARRA-Capital Improvement Program Established in 1967, the main facility of Mission Neighborhood Health Center (MNHC) is located at 240 Shotwell Street, in the heart of the Mission District. The center provides primary care services t to San Franciscos pre... Show more | Health Resources and Services Administration | 6/25/2009 |
| SUTTER WEST BAY HOSPITALS | $675,000 | Trans-NIH Recovery Act Research Support Methamphetamine addiction remains a significant public health problem with no known effective pharmacotherapies. ARRA provided funding for a research project entitled G?Sustained Release Naltrexone for Methamphetamine Dependence: Role of the A118G SNPG?. | National Institutes of Health | 7/16/2009 |
| SUTTER WEST BAY HOSPITALS | $675,000 | Trans-NIH Recovery Act Research Support Methamphetamine addiction remains a significant public health problem with no known effective pharmacotherapies. ARRA provided funding for a research project entitled ?Sustained Release Naltrexone for Methamphetamine Dependence: Role of the A118G SNP?. Th | National Institutes of Health | 7/16/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $661,995 |
Trans-NIH Recovery Act Research Support Title: Estimating the Environmental Burden in Two Orphan Lung Diseases The population attributable fraction (PAF) estimates the amount of a disease that is due to a specific factor, quantifying the burden of disease that would be prevented if that factor
This spending item is part of a $995,960 allocation.
See details
|
National Institutes of Health | 9/30/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $642,209 |
Trans-NIH Recovery Act Research Support Title: 'Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients' - This is a two-year planning grant for a future multi-center, randomized clinical trial assessing the efficacy and safety of immunosuppression withdrawal for stable pe
This spending item is part of a $888,643 allocation.
See details
|
National Institutes of Health | 9/29/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $631,290 |
Trans-NIH Recovery Act Research Support Aim 1: Define mechanisms by which TLR2 activation modulates endothelial cell (EC) expression of coagulation pathway factors in vitro. We defined the role of MAP kinases and NF-kB in EC TLR2 signaling to inflammatory mediators and PAI-1. Notable findings w
This spending item is part of a $687,893 allocation.
See details
|
National Institutes of Health | 6/04/2009 |
| NORTHERN CALIFORNIA INSTITUTE FOR RESEARCH AND EDUCATION, INC. | $624,154 |
Trans-NIH Recovery Act Research Support Heart failure has reached epidemic proportions in the United States and is responsible for nearly 500,000 deaths each year. The majority of heart failure cases is now the result of infarction-induced left ventricular (LV) remodeling. The lack of well-esta
This spending item is part of a $1,552,066 allocation.
See details
|
National Institutes of Health | 8/14/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $604,057 | Trans-NIH Recovery Act Research Support The UCSF DERC provides the infrastructure, core laboratories, pilot and feasibility grants, and enrichment programs that advance the study and treatment of Type1 and Type 2 diabetes. The additional PF support and instrumentation will accentuate the miss | National Institutes of Health | 5/11/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $600,000 | Trans-NIH Recovery Act Research Support HARC Center: HIV Accessory and Regulatory Complexes Viral-host complexes play an integral role in HIV biology. The HARC Center focuses on complexes involved in transmitting the viral genetic information during infection. Three major projects involve HIV | National Institutes of Health | 9/30/2009 |
| RESILIENT NETWORK SYSTEMS, INC. | $600,000 |
Recovery Act Comparative Effectiveness Research - AHRQ We will develop a distributed network infrastructure for comparative effectiveness research that provides flexibility to participant sites in the means for data sharing. This flexibility will be implemented by allowing codification of data shararing polic... Show more
This spending item is part of a $8,309,906 allocation.
See details
|
Agency for Healthcare Research and Quality | 9/28/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $577,058 | Trans-NIH Recovery Act Research Support Project Title: Role of s-nitroso-glutathione reductase in hepatocellular carcinoma. The overall goal of this proposal is to determine if S-nitroso-glutathione reductase is critically important for protection against liver tumorigenesis. We expect that th | National Institutes of Health | 5/08/2009 |
| BLOOD SYSTEMS, INC. | $576,004 |
Trans-NIH Recovery Act Research Support This proposal seeks to apply an innovative, streamlined approach to facilitate the discovery of previously unidentified viral signatures in the several major human cancers from skin, kidney, brain, colon,and the pancreas. This pilot effort will form the b
This spending item is part of a $1,813,010 allocation.
See details
|
National Institutes of Health | 9/28/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $569,318 | ARRA - Scholarships for Disadvantaged Students The Scholarship for Disadvantaged Students promotes diversity among health professions students and practitioners by providing scholarships to students from disadvantaged backgrounds, including students who are members of racial and ethnic minority groupups... Show more | Health Resources and Services Administration | 6/14/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $556,780 | Trans-NIH Recovery Act Research Support In research studies supported by this grant, mutations was discovered in a gene called PTPN11 in pediatric and adult leukemia, which makes a protein called SHP-2. These abnormal SHP-2 proteins cause leukemia and cause developmental disorders by turning on | National Institutes of Health | 7/17/2009 |
| BETASTEM THERAPEUTICS INC | $548,151 |
Trans-NIH Recovery Act Research Support Our specific aims will determine the best time in the natural history of the disease to treat the patient, identify the ideal EPC population to use for therapy, and determine the best method of delivery to the eye. In this proposal, we are using a combina
This spending item is part of a $996,184 allocation.
See details
|
National Institutes of Health | 9/30/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $540,750 | Trans-NIH Recovery Act Research Support Autism spectrum disorders are among the most heritable common disorders, and four times as many males as females are affected. The aims of this proposal comprise a pilot study to investigate the genetic basis for sexual dimorphism in autism. | National Institutes of Health | 9/24/2009 |
| Clinops, LLC | $532,052 | Trans-NIH Recovery Act Research Support Support for data management center personnel to input, quality check, and manage data from the phase 3 NIH Field Administration of Stroke Therapy-Magnesium Trial (FAST-MAG), a study testing a new prehospital treatment for acute stroke. | National Institutes of Health | 9/28/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $500,000 | Trans-NIH Recovery Act Research Support The Shared Instrumentation Grant, Purchase of Applied Biosystems QTRAP 5500 Mass Spectrometry, is to purchase the AB Sciex QTRAP 5500 mass spectrometer. It will be used for reliable quantitation of specific posttranslationally modified peptides down to t | National Institutes of Health | 5/06/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $500,000 | Trans-NIH Recovery Act Research Support The objective of this proposal is to provide a critical system upgrade for the 7T whole body MR scanner at UCSF. Projects that will benefit from the upgrade include translational research programs in cancer, neurological and musculoskeletal diseases. | National Institutes of Health | 6/10/2010 |
| J.DAVID GLADSTONE INSTITUTES, THE | $500,000 |
Trans-NIH Recovery Act Research Support One form of frontotemporal dementia (FTD) is frequently caused by nonsense mutations in a presumed signaling protein, Progranulin (GRN). This project aims to develop and perform preclinical testing of a combinatorial drug treatment approach that aims at r
This spending item is part of a $999,749 allocation.
See details
|
National Institutes of Health | 9/25/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $500,000 |
ARRA - Prevention and Wellness--Communities Putting Prevention to Work Implement a coordinated community action plan comprised seven interventions, including multi-faceted public education campaign, and the implementation of a variety of evidence-based interventions at the city and county-level incluluding comprehensive smoke ... Show more
This spending item is part of a $16,184,860 allocation.
See details
|
Centers for Disease Control and Prevention | 3/18/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $499,982 | Trans-NIH Recovery Act Research Support Biomedical research increasingly relies on quantitative analysis of protein dynamics in living cells to understand normal and disease behaviors. This shared equipment grant is for the acquisition of a new high-end live-cell spinning disk confocal imaging | National Institutes of Health | 5/27/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $499,512 | Trans-NIH Recovery Act Research Support High Performance Computing Cluster for Bioimaging and Computational Biology. To add 1,400 processor cores to the existing shared computing cluster at California Institute for Quantitative Biosciences (QB3) at University of California, San Francisco. The u | National Institutes of Health | 3/18/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $496,140 | Trans-NIH Recovery Act Research Support Genetic and Molecular Epidemiology of Adult Glioma: The purpose of the project is to accelerate progress on our studies of well characterized individual, genomic, and tumor information regarding glioblastoma and other high grade gliomas from a large group | National Institutes of Health | 9/17/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $495,100 | Trans-NIH Recovery Act Research Support To purchase a high-speed fluorescence-activated Cell Sorter, FACSAria II by Becton Dickinson. This instrument will support research in a wide range of research fields e.g. Transplantation, Diabetes, Asthma, Cancer & Immunology | National Institutes of Health | 1/29/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $486,922 | Trans-NIH Recovery Act Research Support Moving a Science-Based Intervention Into Practice. The Mpowerment Project (MP) is an evidence-based HIV-prevention program for young gay/bisexual men. In the original research trials, the MP reached few Black men. We are adapting the MP to their needs bec | National Institutes of Health | 7/31/2009 |
| SAN FRANCISCO STATE UNIVERSITY | $485,270 |
Recovery Act Comparative Effectiveness Research - AHRQ We will develop a distributed network infrastructure for comparative effectiveness research that provides flexibility to participant sites in the means for data sharing. This flexibility will be implemented by allowing codification of data shararing polic... Show more
This spending item is part of a $8,309,906 allocation.
See details
|
Agency for Healthcare Research and Quality | 9/28/2010 |
| HEALTH 2.0, LLC | $480,815 |
ONC Initiative to Support Innovation Scanning
This spending item is part of a $646,041 allocation.
See details
|
Program Support Center | 3/18/2011 |
| NORTHERN CALIFORNIA INSTITUTE FOR RESEARCH AND EDUCATION, INC. | $478,448 | Trans-NIH Recovery Act Research Support This application for an NIH RC1 Challenge Grant in Health and Science Research addresses the following Challenge Areas: (04) Clinical Research and (15) Translation Science. The specific Challenge Topics it addresses are 04-DK-104, Improve the diagnosis, s | National Institutes of Health | 9/30/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $477,304 |
Trans-NIH Recovery Act Research Support This application addresses broad Challenge Area (05) Comparative Effectiveness Research and specific Topic 05-CA-104* Comparative Effectiveness Research on Cancer Treatment. Effectiveness of prostate cancer treatment has been previously evaluated by Marko
This spending item is part of a $996,214 allocation.
See details
|
National Institutes of Health | 9/29/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $472,182 |
Trans-NIH Recovery Act Research Support Specific Aims: Acute Lung Injury (ALI) is a common complication of sepsis and trauma and is associated with mortality of over 20%. Candidate gene studies suggest a role for common genetic variation in determining host susceptibility to ALI in critically
This spending item is part of a $4,676,664 allocation.
See details
|
National Institutes of Health | 9/25/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $470,456 | Trans-NIH Recovery Act Research Support Breast cancer is the second leading cause of cancer deaths in women and is the most common cancer among women. The primary cause of death in breast cancer is metastasis, a process that is still poorly understood, and it is still not possible to accurately | National Institutes of Health | 9/18/2009 |
| SAN FRANCISCO STATE UNIVERSITY | $470,389 |
ARRA - Head Start This action awards a cost of living adjustment (COLA) increase of 1.84%. This action also awards quality improvement funds for Head Start and for Early Head Start.
This spending item is part of a $774,270 allocation.
See details
|
Administration for Children and Families | 7/01/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $469,644 |
Trans-NIH Recovery Act Research Support The name of this grant is Impact of Core Implementation Components on Adoption. This grant supports a study of translational research investigating how effective drug abuse treatments move from multi-site effectiveness research into application in the tre
This spending item is part of a $797,214 allocation.
See details
|
National Institutes of Health | 7/16/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $469,335 | Trans-NIH Recovery Act Research Support Understanding cultural knowledge related to sex and relationships can improve interventions targeting populations at risk for HIV (human immunodeficiency virus). The overall purpose of this research is to improve interventions targeting lower income Afric | National Institutes of Health | 8/04/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $464,598 | Trans-NIH Recovery Act Research Support Currently, there is great interest in the idea of personalized therapy for cancer, based on the notion that each patient's cancer is distinct. However, there remains substantial evidence that cancers also share common, obligate elements that, if adroitly | National Institutes of Health | 9/18/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $464,455 | Trans-NIH Recovery Act Research Support Glioma is a rapidly fatal brain cancer, featuring immunosuppression and abnormal angiogenesis. The project will accelerate progress on studies of immune and angiogenesis markers as predictors of survival in well characterized glioma patients and controls. | National Institutes of Health | 9/25/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $464,294 |
End Stage Renal Disease (ESRD) is a growing public health burden. Cardiovascular disease (CVD) is a major source of morbidity and mortality in patients with ESRD, but optimal strategies for reducing CVD related morbidity and mortality are not fully explor
This spending item is part of a $4,556,778 allocation.
See details
|
Agency for Healthcare Research and Quality | 7/14/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $463,187 |
Trans-NIH Recovery Act Research Support Award Name: New Approaches to Dementia Heterogeneity. This revision to the UCSF Alzheimers Disease Research Center (ADRC) Data Management and Statistics (DMS) core proposes accelerated development of comprehensive data management for the neuropathology c
This spending item is part of a $729,029 allocation.
See details
|
National Institutes of Health | 9/21/2009 |
| SAN FRANCISCO MEDICAL CENTER OUTPATIENT IMPROVEMENT PROGRAMS | $448,730 | ARRA Health Center Integrated Services Development Initiative[g1] ARRA - Capital Improvement Program | Health Resources and Services Administration | 6/29/2009 |
| SUTTER WEST BAY HOSPITALS | $448,704 |
Recovery Act Comparative Effectiveness Research - AHRQ The STONE study, a multi-center randomized controlled trial (RCT), is a comparative effectiveness trial of three different imaging strategies in patients with suspected urolithiasis (kidney stones), seen in the Emergency Department. The study fofocuses on ... Show more
This spending item is part of a $9,154,210 allocation.
See details
|
Agency for Healthcare Research and Quality | 9/28/2010 |
| NORTHERN CALIFORNIA INSTITUTE FOR RESEARCH AND EDUCATION, INC. | $448,658 |
Trans-NIH Recovery Act Research Support Hepatitis B virus (HBV) is a major cause of serious liver diseases, including chronic hepatitis, cirrhosis and hepatocellular carcinoma (HCC) throughout the world and the US, especially among minorities including African Americans, Native Americans, and A
This spending item is part of a $840,347 allocation.
See details
|
National Institutes of Health | 9/24/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $447,999 | Trans-NIH Recovery Act Research Support Award will support studies of secondhand smoke exposure. The funds are being used to purchase a replacement for an obsolete instrument, and allow our facility to support numerous commitments for biofluid analyses for investigators at our institution. | National Institutes of Health | 4/22/2010 |
| NORTHERN CALIFORNIA INSTITUTE FOR RESEARCH AND EDUCATION, INC. | $437,274 |
Trans-NIH Recovery Act Research Support The overall goal of this research is to study alterations in the brain in neurodegenerative diseases, such as Alzheimer's and Parkinson's disease with magnetic resonance imaging (MRI). The proposals in this research amendment all aim at developing novel M
This spending item is part of a $999,850 allocation.
See details
|
National Institutes of Health | 8/24/2009 |
| LUMETRA HEALTHCARE SOLUTIONS | $431,313 |
Trans-NIH Recovery Act Research Support COMPARATIVE EFFECTIVENESS AND OUTCOMES IMPROVEMENT (CEOI) CENTER Despite numerous initiatives over the past three decades to improve healthcare quality and outcomes in the United States, progress remains slow; this is particularly true for chronic diseas
This spending item is part of a $3,855,398 allocation.
See details
|
National Institutes of Health | 9/29/2009 |
| SAN FRANCISCO COMMUNITY CLINIC CONSORTIUM | $431,287 | ARRA Health Center Integrated Services Development Initiative[g1] Increased Demand for Services to San Francisco's Health Care for the Homeless patients. Through this funding, SFCCC and its partner clinics will serve 2,340 new patients (of which 2,270 are uninsured) through 5,310 encounters and retatain 9.98 jobs.... Show more | Health Resources and Services Administration | 3/27/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $431,152 |
Trans-NIH Recovery Act Research Support Infrastructure for Community-Linked Research to Address Disparities in HIV/AIDS To respond to the domestic HIV epidemic in general and reduce health disparities in HIV prevalence specifically, this project will build sustainable infrastructure to enable h
This spending item is part of a $999,777 allocation.
See details
|
National Institutes of Health | 7/06/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $426,622 |
Trans-NIH Recovery Act Research Support The focus of this competing continuation proposal is the localization and characterization of susceptibility genes for Tourette's Disorder (TD) and related conditions. The investigators are members of a longstanding international collaboration, the Touret
This spending item is part of a $1,701,689 allocation.
See details
|
National Institutes of Health | 9/28/2009 |
| NORTHERN CALIFORNIA INSTITUTE FOR RESEARCH AND EDUCATION, INC. | $426,250 | Trans-NIH Recovery Act Research Support The main goals of our parent grant (R01AA10788) are to test in alcohol dependent individuals (i) if chronic smoking influences brain injury, (ii) if chronic smoking effects ares functionally significant, and (iii) to what extent chronic smoking modulates | National Institutes of Health | 8/14/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $424,875 | Trans-NIH Recovery Act Research Support Imaging Nuclear Receptor LRH-1 in Functional Transcriptional Assemblies; Nuclear receptors regulate cell differentiation, metabolism, and can promote cancers. We identify assemblies of nuclear receptor LRH-1 with its regulators. Our goal is to determine s | National Institutes of Health | 5/29/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $424,875 | Trans-NIH Recovery Act Research Support Title: EGFR TARGETING OF THERAPEUTIC LIPOSOMES FOR TREATING GLIOBASTOMA; Purpose and goals: This project is for comparing epidermal growth factor receptor (EGFR) targeted liposome-formulated topotecan (EGFR-LFT) vs. non-targeted liposome-formulated topo | National Institutes of Health | 5/15/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $424,875 | Trans-NIH Recovery Act Research Support Autism-specific mutation in DACT1: Impact on brain development in a mouse model-We are using a novel conditional knock-out mouse line plus neurons in primary culture to test whether a rare variant in the DACT1 locus contributes to the etiology of autism b | National Institutes of Health | 6/08/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $424,875 | Trans-NIH Recovery Act Research Support We have manufactured several peptides from LINE and HERV sequences and tested PBMC from several long term non progressors (LTNPs) and several rapid progressors. The LTNPs had more responses to HERV and LINE peptides thant the rapid progressors. | National Institutes of Health | 9/11/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $424,875 | Trans-NIH Recovery Act Research Support Cell-based therapies for the repair and tissue regeneration of heart tissue, for example following heart infarct, may provide great promise, and human embryonic stem cells are being considered as a cell source for these cells, called cardiomyocytes. We n | National Institutes of Health | 8/14/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $424,874 | Trans-NIH Recovery Act Research Support Src familyGrant name: Src family kinases-mediated ischemic neonatal brain injury Specific aims: Stroke is one of the leading causes of childhood mortality and occurs in 1 out of 4000 live births, an incidence equal to that of stroke in the elderly. H | National Institutes of Health | 6/01/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $424,336 | Trans-NIH Recovery Act Research Support Pregnancy is often a time with increased oral health concerns, yet low rates of dental care utilization. Pregnancy is also a time when women are motivated to take better care of their health for themselves and their unborn infants; thus it is an opportune | National Institutes of Health | 4/29/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $417,800 |
Trans-NIH Recovery Act Research Support The overall goal of this project is to conduct comparative effectiveness research on breast cancer imaging modalities and strategies to inform evidence gaps on how to optimize breast cancer screening in community practice. The Breast Cancer Surveillance C
This spending item is part of a $3,992,841 allocation.
See details
|
National Institutes of Health | 9/30/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $415,653 | Trans-NIH Recovery Act Research Support Conducted a total of 12 educational intervention sessions with 110 people consented and completing a base-line survey (T0). Post-intervention evaluation surveys were completed immediately after the intervention by 95 people(T1) and three-months later by | National Institutes of Health | 7/17/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $414,427 | Trans-NIH Recovery Act Research Support The long term goal of the Innate Immune Response Genetics and T Cell Activation in HIV Treated HIV Infection grant is to better define the determinants of immune recovery during antiretroviral therapy in resource-limited settings in order to optimize the | National Institutes of Health | 5/21/2009 |
| SMITH-KETTLEWELL EYE RESEARCH INSTITUTE, THE | $409,480 | Trans-NIH Recovery Act Research Support The fundamental goal of perception is to infer the structure of the world through an interpretation of temporal and spatial regularities in sensory stimulation that map onto structures in the environment such as objects and surfaces. The goal of this pro | National Institutes of Health | 7/17/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $406,325 | Trans-NIH Recovery Act Research Support The majority of pregnant women in malaria-endemic regions contract placental malaria (PM) at some point during gestation. PM is a severe form of malaria, leading to maternal complications, and negatively affecting the survival and growth of the fetus. PM | National Institutes of Health | 5/06/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $399,053 | Trans-NIH Recovery Act Research Support This is the Final Report. This project is complete. This grant was fully expended. The FFR has been transmitted to the sponsor. Scanned copies of the closeout documents are being emailed to [email protected]. | National Institutes of Health | 2/18/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $397,530 | Trans-NIH Recovery Act Research Support Fungal infections are increasingly important, often fatal complications of intrusive medical procedures ranging from the sustaining therapies for neonates to bone marrow transplantation, chemotherapy and deep surgical procedures. This study is designed t | National Institutes of Health | 5/29/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $396,292 |
Trans-NIH Recovery Act Research Support EVE is a consortium comprised of all U.S. investigators who have conducted genome-wide association studies (GWAS) of asthma and whose main objective is to combine results of individual studies to increase the overall power to identify asthma-susceptibilit
This spending item is part of a $7,375,208 allocation.
See details
|
National Institutes of Health | 9/25/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $393,988 | Trans-NIH Recovery Act Research Support Our work of the 25 years has been instrumental in establishing that the spliceosome is a highly dynamic RNA-protein machine that relies on RNA-dependent ATPases to promote multiple conformational rearrangements during assembly, catalysis, and disassembly. | National Institutes of Health | 9/09/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $393,399 | Trans-NIH Recovery Act Research Support Our ARRA application (parent CPTAC project NIH/NCI U24CA126477) requested salary funds to support an additional phlebotomist. We proposed to prospectively collect and process blood samples from breast cancer patients and healthy women (controls). This add | National Institutes of Health | 9/28/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $391,689 |
Trans-NIH Recovery Act Research Support Hepatitis B virus (HBV) is a major cause of serious liver diseases, including chronic hepatitis, cirrhosis and hepatocellular carcinoma (HCC) throughout the world and the US, especially among minorities including African Americans, Native Americans, and A
This spending item is part of a $840,347 allocation.
See details
|
National Institutes of Health | 9/24/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $386,276 |
Trans-NIH Recovery Act Research Support North American AIDS Cohorts Collaboration on Research and Design A disturbing increase in the incidence of non-AIDS-defining conditions including renal disease, metabolic and cardiovascular disease, and malignancies has been observed in recent years, and
This spending item is part of a $7,312,062 allocation.
See details
|
National Institutes of Health | 9/21/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $386,250 | Trans-NIH Recovery Act Research Support This project studies a protein that is important for regulation of human glucose metabolish because it controls how muscles remove glucose from the bloodstream in response to insulin. Notably the protein of interest called CHC22 clathrin is present in hu | National Institutes of Health | 9/18/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $386,250 | Trans-NIH Recovery Act Research Support The overall hypothesis tested in this proposal is the inflammatory responses in asthma are regulated by the cyclic nucleotide signaling pathway. We have demonstrated that enzymes that degrade inactivate cyclic nucleotides within a cell play a critical fun | National Institutes of Health | 6/21/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $386,250 | Trans-NIH Recovery Act Research Support Non-alcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease in the United States. Epidemiologic studies suggest that fat accumulation per se in the liver is not harmful, but steatosis in combination with another abnormality suc | National Institutes of Health | 7/30/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $384,901 |
Trans-NIH Recovery Act Research Support The name of the grant is Bay Area Breast Cancer & Environment Research Center (BCERC). The purpose of the grant is to provide transdisciplinary center study of environmental determinants of puberty in young girls and pathways through early development of
This spending item is part of a $1,302,049 allocation.
See details
|
National Institutes of Health | 9/02/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $383,923 |
Trans-NIH Recovery Act Research Support The project will strengthen partnerships between the Community Engagement Programs funded by CTSA awards to two institutions, UCSF and Stanford, and their local health departments serving a racially and ethnically diverse population of 2.6 million. The pr
This spending item is part of a $599,933 allocation.
See details
|
National Institutes of Health | 9/28/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $382,656 | Trans-NIH Recovery Act Research Support Award Description:The purpose of this project is to use genetic approaches to understand the cellular processes involved in normal ocular development and disease. We are testing the contribution of mutations in genes encoding for basement membrane collag | National Institutes of Health | 9/29/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $378,278 | Trans-NIH Recovery Act Research Support Title: 'Effect of Obesity on Long-Term Clinical Outcomes after Kidney Donation' - Examine the effects of obesity on long-term renal function and development of cardiavascular risk factors such as hypertension, dyslipidemia, and metabolic syndrome in patie | National Institutes of Health | 9/21/2009 |
| NORTHERN CALIFORNIA INSTITUTE FOR RESEARCH AND EDUCATION, INC. | $371,916 | Trans-NIH Recovery Act Research Support This is a Competitive Revision Application entitled Vitamin D Receptor Coactivators in Keratinocytes in response to Notice Number NOT-OD-09-058 and Notice Title: NIH Announces the Availability of Recovery Act Funds for Competitive Revision Applications. T | National Institutes of Health | 9/28/2009 |
| J.DAVID GLADSTONE INSTITUTES, THE | $370,985 | Trans-NIH Recovery Act Research Support Pathway-oriented visualization of genomic information enables biologists to interpret data in the context of biological processes and systems. We developed GenMAPP (Gene Map Annotator and Pathway Profiler) as a free, open-source, stand-alone computer prog | National Institutes of Health | 8/14/2009 |
| J.DAVID GLADSTONE INSTITUTES, THE | $370,985 | Trans-NIH Recovery Act Research Support Pathway-oriented visualization of genomic information enables biologists to interpret data in the context of biological processes and systems. We developed GenMAPP (Gene Map Annotator and Pathway Profiler) as a free, open-source, stand-alone computer prog | National Institutes of Health | 8/14/2009 |
| SUTTER WEST BAY HOSPITALS | $369,387 |
Trans-NIH Recovery Act Research Support The genetic components of age-related disorders are of intense interest, and genome wide association studies (GWAS) are an important tool in identifying chromosomal loci that are associated with disease. Two of the major and interlinked challenges for suc
This spending item is part of a $830,902 allocation.
See details
|
National Institutes of Health | 9/29/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $368,586 |
ARRA - Health Information Technology - Beacon Communities The purpose of the Beacon Community Cooperative Agreement Program is to provide funding to communities to build and strengthen their Health Information Technology (Health IT)infrastructure and exchange capabilities to demonstrate the vision ofof the future ... Show more
This spending item is part of a $13,525,434 allocation.
See details
|
Health and Human Services, Department of | 5/04/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $366,127 | Trans-NIH Recovery Act Research Support Dry eye is a common pathology in autoimmune disease. Chronic dryness can provoke squamous metaplasia (SQM) of the ocular surface where keratinization and opacification of the cornea can cause blindness. Using the autoimmune regulator (Aire) knockout (KO) | National Institutes of Health | 9/01/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $365,238 | Trans-NIH Recovery Act Research Support This administrative supplement will accelerate the tempo of scientific research, increase participant enrollment and capacity for data analyses, preserve the jobs of current staff, employ new staff and leverage NCI funds in our active grant: Molecular | National Institutes of Health | 9/21/2009 |
| J.DAVID GLADSTONE INSTITUTES, THE | $363,699 |
Trans-NIH Recovery Act Research Support UNAIDS estimates that 14,000 persons are newly infected with HIV every day throughout the world, of which one half are between the ages of 15 and 24. New infections occur despite widespread awareness of the modes of HIV-1 transmission, and the protection
This spending item is part of a $427,526 allocation.
See details
|
National Institutes of Health | 7/22/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $355,315 | Trans-NIH Recovery Act Research Support This grant provided funds for studies on the signal transduction pathways that allow for tuberculosis bacteria to coordinate the expression of virulence factors upon infection of the host. | National Institutes of Health | 7/17/2009 |
| SAN FRANCISCO STATE UNIVERSITY | $355,095 |
Trans-NIH Recovery Act Research Support To support the study to identify psychological and behavioral factors that help prevent gay fathers from HIV risk, substance abuse, and psychological distress as they navigate the myriad life-changing situations faced as parents.
This spending item is part of a $431,363 allocation.
See details
|
National Institutes of Health | 8/14/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $346,114 | Trans-NIH Recovery Act Research Support This ARRA grant for project titled 'Cervical spinal injury and demyelination in aged rats' will develop a model for cervical spinal stenosis and compression injury in aging using a newly-designed spinal compression device in young versus older rats and wi | National Institutes of Health | 5/21/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $345,954 | Trans-NIH Recovery Act Research Support Undercarboxylated osteocalcin, body fat, and diabetes in older adults. This study promises to break new ground by assessing evidence that the bone product, undercarboxylated osteocalcin, has an effect on insulin sensitivity, body fat, and the development | National Institutes of Health | 7/17/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $340,470 | Trans-NIH Recovery Act Research Support The overall aim of this study is to determine the phenotype, function, and role of CD4+CD25+ regulatory T cells (Treg cells) in HIV infected and uninfected humans. | National Institutes of Health | 4/05/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $332,747 |
The Contractor shall provide services to the National Institute of Biomedical Imaging and Bioengineering (NIBIB) in the design, development, and launch of an Internet-based network for patient-controlled medical image sharing built upon the Integrating th
This spending item is part of a $4,697,377 allocation.
See details
|
National Institutes of Health | 9/30/2009 |
| MISSION AREA HEALTH ASSOCIATES | $329,334 | ARRA Health Center Integrated Services Development Initiative[g1] ARRA - Increase Services to Health Centers MNHC provides primary care services to San Francisco's predominantly low-income Latino community. Census data shows that 102,168 persons live in the census tracts enclosed in MNHC's service a area of which 41,724 ... Show more | Health Resources and Services Administration | 3/27/2009 |
| BETASTEM THERAPEUTICS INC | $326,697 | ARRA - Community Services Block Grant The long term goal is to develop an efficient, safe clinical treatment for diabetic retinopathy using stem cells from the patient's bone marrow or blood that have been activated to repair damaged vessels in the eye. Diabetic retinopathy remains theleading | National Institutes of Health | 9/30/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $323,402 | Trans-NIH Recovery Act Research Support R01MH080283-03S1 Dynamic Analysis of Neural Plasticity in the Hippocampal Circuit. The purpose of this grant is to understand the role of awake memory replay in learning and memory. We found that as animals learn about a new place there is frequent awake | National Institutes of Health | 9/28/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $321,756 |
Trans-NIH Recovery Act Research Support Purpose: The aim of the HEARTS study is to better understand the distribution and correlates of Human Papilloma Virus (HPV) among homeless and unstably housed women. Goal: The overall goal of the study is to provide population-specific inform for pre
This spending item is part of a $345,003 allocation.
See details
|
National Institutes of Health | 8/11/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $321,562 | Trans-NIH Recovery Act Research Support The title of this award is Adherence and the Economics of Colon Cancer Screening. The aim of this administrative supplement is to compare programmatic adherence to competing strategies to reduce mortality from colorectal cancer, where programmatic adhere | National Institutes of Health | 9/09/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $317,152 |
Trans-NIH Recovery Act Research Support Award Title: 1R21ES017763-01: Assessing maternal and fetal exposure to chemicals during the second trimester. Purpose: The purpose of this grant is to test several hypotheses surrounding maternal and fetal exposures to bisphenol A (BPA). First, we would
This spending item is part of a $372,724 allocation.
See details
|
National Institutes of Health | 9/04/2009 |
| ASIAN AND PACIFIC ISLANDER AMERICAN HEALTH FORUM | $316,768 |
Trans-NIH Recovery Act Research Support This administrative supplement to the parent grant of the NYU Center for the Study of Asian American Health (CSAAH) will provide support to establish an innovative and national scientific partnership with CSAAH, the Asian & Pacific Islander American Heal
This spending item is part of a $599,672 allocation.
See details
|
National Institutes of Health | 9/18/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $315,888 |
Trans-NIH Recovery Act Research Support This proposal seeks to apply an innovative, streamlined approach to facilitate the discovery of previously unidentified viral signatures in the several major human cancers from skin, kidney, brain, colon,and the pancreas. This pilot effort will form the b
This spending item is part of a $1,813,010 allocation.
See details
|
National Institutes of Health | 9/28/2009 |
| NORTHERN CALIFORNIA INSTITUTE FOR RESEARCH AND EDUCATION, INC. | $308,535 | Trans-NIH Recovery Act Research Support Alveolar epthelial wound healing is required for recovery from acute lung injury and ARDS, but the mechanisms for epithelial repair in the lung are not fully understood. Previous work has shown that one pathway that promotes epithelial migration and repai | National Institutes of Health | 8/12/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $307,770 |
Trans-NIH Recovery Act Research Support Purpose: to examine deficits in planning movements, specifically task switching, due to Parkinson's disease (PD). Task switching is the ability to make a change in the plan (switching from one response option to another, e.g. pressing one button vs. anot
This spending item is part of a $1,223,856 allocation.
See details
|
National Institutes of Health | 7/22/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $307,209 | Trans-NIH Recovery Act Research Support In research studies supported by this grant, we discovered mutations in a gene called PTPN11 in pediatric and adult leukemia, which makes a protein called SHP-2. These abnormal SHP-2 proteins cause leukemia and cause developmental disorders by turning on | National Institutes of Health | 9/25/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $307,206 | Trans-NIH Recovery Act Research Support Goals and Project Purpose: This supplement funds a post-doctoral scholar and a pre-doctoral research assistant for the purpose of accelerating and enhancing the tempo and productivity of the current project. The goals of the parent are to develop and appl | National Institutes of Health | 9/01/2009 |
| SUTTER WEST BAY HOSPITALS | $306,201 |
Trans-NIH Recovery Act Research Support Overall Purpose. Loss of mobility characterized by slowing gait speed, exertional fatigue and exhaustion is a hallmark of age-related functional decline. Current studies have not explained the biological reason for this slowing and loss of mobility. In pa
This spending item is part of a $855,594 allocation.
See details
|
National Institutes of Health | 9/30/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $305,539 | Trans-NIH Recovery Act Research Support Grant Name: Neural Mechanisms Underlying Cognitive Aging: The goal of the parent R01 is to identify alterations in fundamental neural mechanisms that underlie a wide range of age-related cognitive deficits, so that we can generate a unifying cognitive ag | National Institutes of Health | 9/04/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $300,000 | ARRA - Dental Public Health Residency Training Grants The ?Expanding the Dental Public Health Workforce? award will support the Residency Training in Dental Public Health at the University Of California School Of Dentistry in San Francisco. The Postgraduate Program in Dental Public Health is designened to pro... Show more | Health Resources and Services Administration | 9/03/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $298,479 | Trans-NIH Recovery Act Research Support Cancer cell telomere dynamics and responses to perturbaturbations The parent grant analyzes telomere behavior, the consequences of telomere malfunctioning, and telomerase activation and inactivation in human cancer cells. Those Aims are: Aim 1. Analyze re | National Institutes of Health | 9/01/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $298,193 | Trans-NIH Recovery Act Research Support The ARRA supplement to the IRACDA Scholars in Science (ISIS) parent grant enables UCSF to increase the number of ISIS Fellows who benefit from mentored teaching and career-enhancing training. The supplement also provides current ISIS Fellows with the opp | National Institutes of Health | 7/14/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $296,377 | ARRA ? Equipment to Enhance Training for Health Professionals The California Area Health Education Center (AHEC) Programs ARRA Equipment to Enhance Training for Health Professions grant provides simulation equipment to train health professions students and health professionals in California, preparining them to work i... Show more | Health Resources and Services Administration | 9/02/2010 |
| KAISER FOUNDATION HOSPITALS | $295,077 |
Trans-NIH Recovery Act Research Support Identify the barriers in implementing individualized informed consents in routine clinical care. Test the impact of Personalized Risk Information Services Manager (PRISM) on the quality of informed consent, on the use of Bleeding Avoidance Therapies (BAT
This spending item is part of a $4,173,058 allocation.
See details
|
National Institutes of Health | 9/18/2009 |
| J.DAVID GLADSTONE INSTITUTES, THE | $289,500 | Trans-NIH Recovery Act Research Support Obesity and related diseases, such as diabetes, occur when there is an overload of triglycerides in the fat and other tissues. This grant focuses on studying all aspects of the basic biology of the enzymes (called DGATS) that make triglycerides. Since D | National Institutes of Health | 9/30/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $289,326 | Trans-NIH Recovery Act Research Support This ARRA grant for project titled Preclinical development of a gene therapy for Niemann-Pick disease, type A provides research involving rodent and non-human primate experiments studying lysosomal dysfunction in Niemann-Pick Disorder (NPD) Type A, to det | National Institutes of Health | 8/17/2009 |
| NORTHERN CALIFORNIA INSTITUTE FOR RESEARCH AND EDUCATION, INC. | $289,157 | Trans-NIH Recovery Act Research Support No cardiovascular disease has proved more recalcitrant than dilated cardiomyopathy and heart failure, as the best pharmacologic treatments slow, but do not reverse, the progression to end stage disease. Hope remains high for surgical interventions, and th | National Institutes of Health | 7/16/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $289,114 |
Trans-NIH Recovery Act Research Support The goal of this project is to use contemporary genomic profiling approaches to identify genetic alterations contributing to the pathogenesis and treatment outcome of high risk acute leukemia. Despite best current therapy, acute lymphoblastic leukemia rem
This spending item is part of a $1,573,220 allocation.
See details
|
National Institutes of Health | 9/30/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $288,245 | Trans-NIH Recovery Act Research Support The purpose of the UCSF Liver Center is to help scientists perform better research at a faster pace and place them in a position for individual research support by NIH/NIDDK. To achieve its goals, the Center provides three types of benefits: (1) research | National Institutes of Health | 7/20/2009 |
| AMERICAN ACADEMY OF OPHTHALMOLOGY, INC. | $287,591 |
The Registry for 'Comparative Effectiveness of Treatment Strategies for Primary Open Angle Glaucoma' task order has 5 primary objectives. 1) Identify decisions under consideration by stakeholders for which available scientific evidence is insufficient to
This spending item is part of a $4,055,617 allocation.
See details
|
Health and Human Services, Department of | 7/13/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $285,546 | Trans-NIH Recovery Act Research Support T brucei cells r synchronized&released for synchronous cell cycle progression. Inhibitor of T brucei Aurora B kinase r added @ different times.2 distinctive actions of Aurora B r demostrated; transition of metaphase to anaphase&initiation of cytokinesis | National Institutes of Health | 6/04/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $285,305 |
Trans-NIH Recovery Act Research Support The CFAR Network of Integrated Clinical Systems (CNICS), headquartered at UAB, was funded in September 2006 via the R24 mechanism. This supplement is to fund increased capacity for sample repositorys at UAB and each of the designated CNICS sites through
This spending item is part of a $1,825,789 allocation.
See details
|
National Institutes of Health | 9/21/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $280,753 | Trans-NIH Recovery Act Research Support The NIH Human Endometrial Tissue and DNA Bank, a national resource founded in 2000, resides in our NIH U54 SCCPIR Center at UCSF and serves as a repository for human endometrial tissue, DNA, and blood specimens for SCCPIR and other NIH investigators. To | National Institutes of Health | 9/28/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $279,211 |
Trans-NIH Recovery Act Research Support The broad aim of this Grand Opportunity Grant is to understand how race-based social stress, racial/ethnic (R/E) identity, and biological functioning contribute to health and healthy aging. Using the Maryland Adolescent Development in Context Study (MADIC
This spending item is part of a $900,235 allocation.
See details
|
National Institutes of Health | 9/29/2009 |
| SMITH-KETTLEWELL EYE RESEARCH INSTITUTE, THE | $277,097 | Trans-NIH Recovery Act Research Support Using a variety of techniques including functional brain imaging, EEG and psychophysics to study how color signals are processed and represented in the early human visual system. | National Institutes of Health | 8/11/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $274,273 |
Trans-NIH Recovery Act Research Support Effective prevention strategies for HIV are critically needed, and an effective HIV vaccine is the best long-range hope to dramatically reduce the rate of new HIV infections. To this goal, our current understanding of the biology and epidemiology of HIV t
This spending item is part of a $2,113,918 allocation.
See details
|
National Institutes of Health | 5/03/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $270,941 | Trans-NIH Recovery Act Research Support Project Title: Gene Targeted Mice with a Simplified Immune System. The purpose of the project is to define the connection between endogenous retroelements and autoimmunity, specifically, for lupus,Aicardi-Gouti+?res syndrome, and type 1 diabetes. The goa | National Institutes of Health | 7/12/2010 |
| NORTHERN CALIFORNIA INSTITUTE FOR RESEARCH AND EDUCATION, INC. | $263,810 | Trans-NIH Recovery Act Research Support The goal of the parent grant (R01 HL79235) is to understand how depression leads to heart failure (HF) in older adults. Depression is an important risk factor for the development of HF and for adverse outcomes in patients with existing HF. However, the me | National Institutes of Health | 8/10/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $259,938 | Trans-NIH Recovery Act Research Support Pharmaceutical Sciences and Pharmacogenomics Graduate Program (PSPG) is a cross-disciplinary program that consists of scientists at the University of California, San Francisco (UCSF) working in pharmaceutical sciences, computation and contemporary genetic | National Institutes of Health | 8/13/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $258,800 | Trans-NIH Recovery Act Research Support This research project studies opportunistic pneumonias in HIV-infected persons and explores factors associated with mortality from Pneumocystis pneumonia (PCP), a leading AIDS-defining pneumonia and cause of death. | National Institutes of Health | 7/16/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $258,144 | Trans-NIH Recovery Act Research Support This shared equipment grant is for a 12-chamber Comprehensive Lab Animal Monitoring System (CLAMS) that enables efficient and precise measurements of feeding, basal metabolism, motor activities, and thermoregulation in mice. The accurate measurements of t | National Institutes of Health | 7/22/2010 |
| J.DAVID GLADSTONE INSTITUTES, THE | $256,426 |
Trans-NIH Recovery Act Research Support We are creating stem cells from human skin cells (we call these stem cellsinduced pluripotential stem cells or iPSCs). Thus, we are able to make stem cells for individual people. These iPSCs have the potential to become any cell in the body. We are abl
This spending item is part of a $2,696,700 allocation.
See details
|
National Institutes of Health | 9/28/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $254,216 | Trans-NIH Recovery Act Research Support Award description: Studies suggest that a large proportion of travelers engage in behaviors that place them at risk for HIV, hepatitis B (HBV) and hepatitis C (HCV) infection. As a supplement to the grant entitled 'International Mobility of HIV', we will | National Institutes of Health | 3/23/2010 |
| CITY & COUNTY OF SAN FRANCISCO | $253,000 |
ARRA - Immunization ARRA-317 Immunization and Vaccines for Children Grants. This award will support efforts to plan, develop, and maintain a public health infrastructure for low income children and adults vaccinated against vaccine-preventable diseases.
This spending item is part of a $10,069,863 allocation.
See details
|
Centers for Disease Control and Prevention | 9/15/2009 |
| NORTHERN CALIFORNIA INSTITUTE FOR RESEARCH AND EDUCATION, INC. | $251,720 | Trans-NIH Recovery Act Research Support Funding to hire a new research assistant full time employee (FTE) would be invaluable in helping us accelerate the pace and expand the scope of research aims currently funded by my parent R01 grant that are focused on elucidating the role of apoE isoforms | National Institutes of Health | 7/16/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $251,299 |
Trans-NIH Recovery Act Research Support This project is designed to complete the scientific planning and administrative activities that are required to conduct a clinical trial on the efficacy of lifestyle intervention to treat obese men with erectile dysfunction (ED). ED is a significant publ
This spending item is part of a $726,805 allocation.
See details
|
National Institutes of Health | 9/29/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $249,719 | ARRA - Nurse Faculty Loan Program Nurse Faculty Loan Program funds are used to prepare graduates to serve as faculty in a school of nursing. Loans are made to students who are enrolled full or part-time in an advanced degree program?master?s or doctoral ? in nursing. The degree program | Health Resources and Services Administration | 6/14/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $249,251 | Trans-NIH Recovery Act Research Support San Francisco Mammography Registry-A Research Source -- We examined the influence of dense volume and texture features by type of breast cancer [ductal carcinoma in situ (DCIS) vs. invasive cancer]. Using 168 invasive breast cancers and 504 controls and 6 | National Institutes of Health | 8/28/2009 |
| Ucsf Mount Zion Medical Center | $247,596 |
Trans-NIH Recovery Act Research Support Advanced, metastatic prostate cancer that progresses following hormone (androgen) suppression, has no known cure, and contributes to substantial morbidity and mortality. This proposal aims to categorize advanced castration-resistant prostate cancers into
This spending item is part of a $996,908 allocation.
See details
|
National Institutes of Health | 9/29/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $245,141 |
Trans-NIH Recovery Act Research Support This project will provide post-doctoral fellows and junior faculty from the health and empowerment sciences an intensive, interdisciplinary, hands-on, mentored research experience at the intersection of women's health and empowerment.
This spending item is part of a $415,565 allocation.
See details
|
National Institutes of Health | 9/26/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $238,616 | Trans-NIH Recovery Act Research Support The long-term objective of this proposal is to elucidate the cellular basis for bone marrow failure (BMF) in X-linked Dyskeratosis Congenita (X-DC), an inherited disease characterized by early mortality due to aplastic anemia. X-DC is one of the main inhe | National Institutes of Health | 8/01/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $235,562 | Trans-NIH Recovery Act Research Support This research supports the development of improved computational methods for design of novel human therapeutics using structure-based approaches and approaches based purely on machine learning. The goals are to develop predictive computational techniques | National Institutes of Health | 9/30/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $231,750 | Trans-NIH Recovery Act Research Support Understanding how HIV replicates, how its genome is transcribed, how its nascent transcripts are processed and how its genetic material is translated into proteins that form new viral particles are critical questions in virology and human health. This Sup | National Institutes of Health | 9/27/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $230,464 | Trans-NIH Recovery Act Research Support The purpose of this project is to develop methods to address the complexity of modern PKPD population studies focusing on computational PKPD and modeling of comples PKPD systems. Aim1: to investigate modern algorithms and approximations to the likelihood | National Institutes of Health | 9/08/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $228,059 | Trans-NIH Recovery Act Research Support This project titled 'GPU Computing Enabled Linux Computer Cluster ' is to set up a medium-sized specialized GPU computing enabled computer cluster equipment for fast processing of very large electron cryomicroscopy (cryoEM) datasets to facilitate routinel | National Institutes of Health | 1/28/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $225,570 | Trans-NIH Recovery Act Research Support This supplement supported seven high school students, two undergraduate students, and two teachers in a Summer Research Experience in the Lim lab at UCSF to teach research skills. | National Institutes of Health | 6/22/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $225,260 | Trans-NIH Recovery Act Research Support Grant name: Hair Extension. Purpose: To extend aims of the parent grant with evaluation of drug levels in hair as a predictor of response to ART in South African adult and Ugandan pediatric ART recipients and to develop methods for measuring antimycobac | National Institutes of Health | 7/12/2010 |
| SAN FRANCISCO STATE UNIVERSITY | $225,000 | ARRA - Head Start This award provides for ARRA Early Learning Mentor Coaches to support Teachers in delivering evidence-based educational practices to 324 low-income children in the City and County of San Francisco. Head Start promotes the school readiness of low-income ch | Administration for Children and Families | 9/16/2010 |
| HEBREW HOME FOR AGED DISABLED | $225,000 | Trans-NIH Recovery Act Research Support SPECIFIC AIMS for 2R56AG015982-11 The goals of the R56 will be to perform a randomized double-blind placebo controlled trials to investigate the vitamin D effects on CYP3A4- mediated drug clearance of atorvastatin and /or decreases serum lipid concentra | National Institutes of Health | 9/17/2010 |
| HEBREW HOME FOR AGED DISABLED | $225,000 | Trans-NIH Recovery Act Research Support SPECIFIC AIMS for 2R56AG015982-11 The goals of the R56 will be to perform a randomized double-blind placebo controlled trials to investigate the vitamin D effects on CYP3A4- mediated drug clearance of atorvastatin and /or decreases serum lipid concentra | National Institutes of Health | 9/17/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $224,820 |
Trans-NIH Recovery Act Research Support The project entails stereologic validation of a murine model of traumatic brain injury based upon MRI changes in brain-injured children and testing the efficacy of matrix metalloproteinase inhibitor in supporting structural recovery in the animal model.
This spending item is part of a $424,704 allocation.
See details
|
National Institutes of Health | 8/04/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $224,040 | Trans-NIH Recovery Act Research Support We have completed the hypoxia-ischemia experiments on hybrid GPx over-expressors x IF-knock-out pups. Since oxidative stress initiates hypoxic-ischemic brain injury and the neonatal brain may be particularly vulnerable to this stress, we have previously s | National Institutes of Health | 9/15/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $224,025 | Trans-NIH Recovery Act Research Support The original aims of the grant remain the same: 2.1. Specific Aim 1: To characterize the epitopes recognized by HIV-1 protease and LINE specific T cells in HIV-1 exposed uninfected subjects. 2.2 Specific Aim 2: To determine the efficacy of anti-HIV-1 prot | National Institutes of Health | 5/17/2010 |
| NORTHERN CALIFORNIA INSTITUTE FOR RESEARCH AND EDUCATION, INC. | $222,300 | Trans-NIH Recovery Act Research Support Osteoporosis is a serious disorder of ageing men and women, and is prevalent in the veteran population. The present studies are designed to define the mechanisms that control normal bone formation and that are necessary and sufficient for anabolic respon | National Institutes of Health | 4/05/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $219,133 |
Although the incidence of ductal carcinoma in situ (DCIS) has risen dramatically within the last 20 years, the long term consequences of different DCIS treatment strategies are not well understood. Treatment options for DCIS include type of surgery (lumpe
This spending item is part of a $3,040,076 allocation.
See details
|
Agency for Healthcare Research and Quality | 7/13/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $218,105 |
Trans-NIH Recovery Act Research Support Our preliminary studies based on proton nuclear magnetic resonance spectroscopy (1H-NMR) show that multivariate analysis of the NMR spectra recorded for culture media samples from 100% and 0% implantation cases revealed a statistical separation of the two
This spending item is part of a $475,651 allocation.
See details
|
National Institutes of Health | 9/22/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $215,875 | Trans-NIH Recovery Act Research Support Grant name: Novel small-molecule therapies for CF. The purpose of this project is to identify small-molecule inhibitors of P.aeruginosa biofilm formation for CF therapy. This second year of this pilot will focus on: (i) further screening and optimizatio | National Institutes of Health | 8/06/2010 |
| SAN FRANCISCO MEDICAL CENTER OUTPATIENT IMPROVEMENT PROGRAMS | $213,785 | ARRA Health Center Integrated Services Development Initiative[g1] ARRA - Increase Services to Health Centers Purpose of the IDS Grant - This grant allowed SMHC to minimize planned cuts for dental and restore services to the pre-2008 levels. SMHC grant award helped reduced impending staff cuts in itits Dental Health prog... Show more | Health Resources and Services Administration | 3/27/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $213,494 | Trans-NIH Recovery Act Research Support The overall design of the study is a Randomized Cluster Control Trial to examine the effects of the Non-pneumatic Anti-shock Garment (NASG) as a first-aid device for obstetric hemorrhage at the District Clinics (clinics) in Zambia and Zimbabwe. | National Institutes of Health | 9/23/2009 |
| WU YEE CHILDREN'S SERVICES | $212,852 | ARRA - Early Head Start Early Learning Mentor Coach to improve the quality of services delievered to the 110 Early Head Start children in our program. The project will provide direct individualized mentoring and coaching to 23 Wu Yee staff members and leverage funded training fo | Administration for Children and Families | 9/16/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $212,391 |
Trans-NIH Recovery Act Research Support This study examines 1800 patients treated at more than 20 centers with expertise in robotic and standard prostate surgery; the patients have been evaluated for quality of life before and after surgery, and for complications, costs, and cancer control. WeG
This spending item is part of a $1,000,000 allocation.
See details
|
National Institutes of Health | 9/22/2009 |
| NORTHERN CALIFORNIA INSTITUTE FOR RESEARCH AND EDUCATION, INC. | $209,241 | Trans-NIH Recovery Act Research Support This is a request for an Recovery Act Administrative Supplement for NIH grant GM61616. The supplement will speed up progress and importantly provide continued employment for well trained scientists working in the area of the structure and function of memb | National Institutes of Health | 9/25/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $206,532 | Trans-NIH Recovery Act Research Support Award Description: PROJECT SUMMARY: About 1-2% of American children have abnormal binocular vision, characterized by misalignment of the eyes. This condition is called strabismus. The goal of this project is to understand how the brain compensates for str | National Institutes of Health | 1/07/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $205,541 | Trans-NIH Recovery Act Research Support This award is a Recovery Act Administrative Supplement, which provides supplementary funding for an ongoing NIH R01 grant (R01-GM053270-19; PI: Morgan, D.O. ; Title: Molecular Control of Cell Proliferation). Specifically, supplement funds were used to (1) | National Institutes of Health | 8/03/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $201,623 | Trans-NIH Recovery Act Research Support R01 CA126792-01A2S1 (Autophagy and Epithelial Cell Fate during Anoikis and 3D Morphogenesis): This ARRA Competitive Revision tests the requirement for detachment-induced autophagy during cancer cell dissemination and metastasis using in vivo models of exp | National Institutes of Health | 9/21/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $201,509 |
Trans-NIH Recovery Act Research Support Severe asthma, a heterogeneous disease consisting of related clinical phenotypes, generates high levels of morbidity, mortality and health care costs. The complexity and heterogeneity of the disorder have limited clinical advances. However, the NHLBI Seve
This spending item is part of a $3,489,267 allocation.
See details
|
National Institutes of Health | 9/25/2009 |
| NORTHERN CALIFORNIA INSTITUTE FOR RESEARCH AND EDUCATION, INC. | $193,463 | Trans-NIH Recovery Act Research Support The purpose of this study is to enhance risk prediction through secondary data collection and analysis in an ongoing randomized clinical trial (RCT) of neuroplasticity-based cognitive training for young people at ultra-high-risk psychosis. Although the pr | National Institutes of Health | 9/29/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $193,370 | Trans-NIH Recovery Act Research Support This supplemental project is focused on accelerating and enhancing the tempo and productivity of the parent project developing new hyperpolarized metabolic imaging methods by funding a new post-doctoral position. This post-doctoral fellow will develop spe | National Institutes of Health | 8/13/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $191,802 | Trans-NIH Recovery Act Research Support The therapeutic potential of small fragment homologous replacement (SFHR), developed in the PIs laboratory, was evaluated. Three Specific Aims will be pursued: Aim 1 - Optimize SFHR frequency by testing different sizes and types (single versus double stra | National Institutes of Health | 9/23/2010 |
| SAN FRANCISCO, CITY & COUNTY OF | $190,832 |
Aging Congregate Nutrition Services for States Provides additional funding to Area Agencies on Aging for Elderly Nutrition Congregate Meals Programs to feed seniors in need and to restore nutrition services and local food service positions eliminated due to cost increases and funding losses.
This spending item is part of a $6,585,441 allocation.
See details
|
Administration on Aging | 3/18/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $190,682 |
Trans-NIH Recovery Act Research Support Bacteria are among the simplest organisms in nature, but perform critical functions for life on earth including generating energy, recycling minerals and degrading environmental toxins. Additionally, disease-causing bacteria are a major risk to human hea
This spending item is part of a $408,929 allocation.
See details
|
National Institutes of Health | 7/17/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $190,520 | Trans-NIH Recovery Act Research Support this supplement was to hire an additonal post-doctoral fellow to work on characterization of the methyl transfer reaction in the biosynthesis of thienamycin and to purchase additonal equipment to accelerate the pace of research for the parent grant. | National Institutes of Health | 3/29/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $189,941 | Trans-NIH Recovery Act Research Support Award Description: This is the final report for this award. Project is completed and two publications have been published to this date. A third manuscript is submitted. | National Institutes of Health | 9/01/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $187,302 | Trans-NIH Recovery Act Research Support The goal of this grant is to explore the role of gap junctions in regulating neural stem and progenitor cell proliferation and neuronal migration. Recently, we expanded our goals to study gap junction regulation of microcircuit formation. Our first stra | National Institutes of Health | 9/30/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $185,781 |
Trans-NIH Recovery Act Research Support The overall goal of these continuing studies is to understand how endothelial nitric oxide synthase (eNOS) signaling is regulated in the pulmonary system with emphasis on its role in the perinatal period. We have recently demonstrated in vivo, that endoth
This spending item is part of a $977,179 allocation.
See details
|
National Institutes of Health | 8/31/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $185,000 | Trans-NIH Recovery Act Research Support The goal of this research is to improve cancer treatment using ligand-targeted liposome encapsulated drugs. Liposomes are microscopic, spherical structures prepared from phospholipids. Cancer drugs can be encapsulated inside the liposome. In this research | National Institutes of Health | 8/31/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $183,585 |
Trans-NIH Recovery Act Research Support The primary specific aim of our parent grant is G?to determine the effects of low glycemic load diets on insulin, carbohydrate, and fat metabolism in obese, pregnant women stratified by visceral fat thickness.G? We hypothesize that a low glycemic load (G
This spending item is part of a $198,367 allocation.
See details
|
National Institutes of Health | 9/22/2009 |
| SAN FRANCISCO STATE UNIVERSITY | $183,096 | Trans-NIH Recovery Act Research Support The Spectrum initiative will pioneer a multi-pronged program that brings together K-12 teachers and students with biomedical scientists from multiple stages of the research career pthway to learn together about the biology behind women's health issues, ab | National Institutes of Health | 9/17/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $182,715 | Trans-NIH Recovery Act Research Support Project Abstract: The neuromuscular junction of Drosophila is highly homologous to the mammalian neuromuscular junction and is amenable to powerful forward genetic screening that is not possible in vertebrates. Forward genetic approaches in Drosophila can | National Institutes of Health | 9/25/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $182,066 | Trans-NIH Recovery Act Research Support The title of grant #R01 HL086917 is The role of nitric oxide synthase in circulating progenitor cell function. The main goal of this project is to determine whether correlations exist between endothelial dysfunction, endothelial progenitor cell dysfuncti | National Institutes of Health | 7/16/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $180,592 |
Trans-NIH Recovery Act Research Support We have proposed to define the contribution of the major histocompatibility complex (MHC) genomic region to the risk of rheumatoid arthritis (RA). During the past five years we have made substantial progress as part of our parent grant, including completi
This spending item is part of a $233,203 allocation.
See details
|
National Institutes of Health | 6/28/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $180,000 | ARRA Grants for Training in Primary Care Medicine and Dentistry Training and Enhancement Over the past 30 years, thousands of people with developmental disabilities (DD) have moved from institutions to the community. This movement has required a remarkable transfer of services that were once availablble only in institutions. Over the same time... Show more | Health Resources and Services Administration | 8/20/2010 |
| BETASTEM THERAPEUTICS INC | $177,238 |
Trans-NIH Recovery Act Research Support The long term goal is to develop an efficient, safe clinical treatment for diabetic retinopathy using stem cells from the patient's bone marrow or blood that have been activated to repair damaged vessels in the eye. Diabetic retinopathy remains theleading
This spending item is part of a $326,697 allocation.
See details
|
National Institutes of Health | 9/30/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $176,302 |
Trans-NIH Recovery Act Research Support This research project seeks to improve understanding of the connection of bone marrow fat (BMF) with bone density, geometry and turnover by recruiting 150 men who are currently participating in the Osteoporotic Fractures in Men (MrOS) study at the Pittsbu
This spending item is part of a $857,596 allocation.
See details
|
National Institutes of Health | 9/28/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $175,442 | Trans-NIH Recovery Act Research Support This project titled 'Anachem Lipidic Cubic Phase Crystallization Robot' is to purchase a lipidic cubic phase robot equipment to facilitate structure determination of membrane proteins in their lipid environments. Membrane proteins constitute about 30% o | National Institutes of Health | 2/20/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $175,049 | Trans-NIH Recovery Act Research Support We have recorded and analyzed data from a large group of neurons in the Abducens nucleus and compared the neuron-behavior correlations in different neuron types. | National Institutes of Health | 1/07/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $172,444 |
Trans-NIH Recovery Act Research Support Patient recruitment and retention Patient recruitment and retention of study subjects has been excellent in this study. The COMET Network was able to screen 108 potential subjects. From these there were 12 screen fails, 3 subjects withdrew consent, two
This spending item is part of a $7,915,507 allocation.
See details
|
National Institutes of Health | 9/28/2009 |
| MISSION NEIGHBORHOOD CENTERS, INC. | $168,122 |
ARRA - Head Start This action awards a cost of living adjustment (COLA) increase of 1.84%. This action also awards quality improvement funds for Head Start and for Early Head Start.
This spending item is part of a $774,270 allocation.
See details
|
Administration for Children and Families | 7/01/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $164,267 | Trans-NIH Recovery Act Research Support The goal is to provide funding for personnel and technology for 2 major enhancements to main grant, incl. active recruit. of subjects with acute HIV infection, & process. & analysis of diffusion tensor imaging obtained in primary infection subjects. | National Institutes of Health | 3/31/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $162,998 |
Trans-NIH Recovery Act Research Support Attention Deficit Hyperactivity Disorder, Predominantly Inattentive Type (ADHD-I) is a prevalent and serious childhood psychiatric disorder, adversely impacting a child's functioning at school, at home, and with peers. This study provides for a study of c
This spending item is part of a $336,367 allocation.
See details
|
National Institutes of Health | 7/21/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $159,948 | ARRA - Scholarships for Disadvantaged Students Program provides scholarship funds to financially needy students from disadvantaged backgrounds enrolled in health professional programs and helps reduce the loan amounts students need to obtain to meet their educational expenses. | Health Resources and Services Administration | 9/03/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $154,559 | Trans-NIH Recovery Act Research Support Grant Name: Can drug aggregation affect physiologic distribution? (Supplement to GM71630). The key goal was to test whether drugs form colloidal aggregates in the intestine, and whether this affects their distribution. This was to be investigated by det | National Institutes of Health | 8/13/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $154,500 | Trans-NIH Recovery Act Research Support Project was completed as of 5/31/11. Final award description and progress report were reported in the last reporting period Apr-Jun 2011. | National Institutes of Health | 6/04/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $154,500 | Trans-NIH Recovery Act Research Support This is the Final Report. This project is complete. The FFR has been transmitted to the sponsor. Scanned copies of the closeout documents are being emailed to [email protected]. | National Institutes of Health | 5/08/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $154,500 | Trans-NIH Recovery Act Research Support This project uses mice engineered with specific genetic changes in order to recreate Lowe Syndrome and study the renal pathology as it pertains to Lowe and other diseases. | National Institutes of Health | 9/30/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $154,500 | Trans-NIH Recovery Act Research Support Circulation of white blood cells through lymphoid tissues is essential for initiation of immune responses to infectious microorganisms such as viruses but could also have detrimental consequences in chronic inflammatory and autoimmune diseases. CD8 T cel | National Institutes of Health | 7/26/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $154,226 |
Trans-NIH Recovery Act Research Support This application entitled, 'Discovering Pathways of Functional Decline: A GWAS Approach' addresses the challenge area (08): Genomics and the specific challenge topic, 08-AG-101: Genetic factors affecting rates of change in disease risk factors with age. T
This spending item is part of a $814,020 allocation.
See details
|
National Institutes of Health | 9/24/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $151,427 |
Trans-NIH Recovery Act Research Support Patient recruitment and retention Patient recruitment and retention of study subjects has been excellent in this study. The COMET Network was able to screen 108 potential subjects. From these there were 12 screen fails, 3 subjects withdrew consent, two
This spending item is part of a $7,915,507 allocation.
See details
|
National Institutes of Health | 9/28/2009 |
| BRANAGH INFORMATION GROUP, INC. | $150,360 |
ARRA Child Care and Development Block Grant ARRA DISCRETIONARY FUNDING FOR CHILD CARE DEVELOPMENT - Grants for states, territories, tribes and tribal organizations for child care assistance for low income working families and fund activities to improve the quality of child care.
This spending item is part of a $5,747,006 allocation.
See details
|
Administration for Children and Families | 4/09/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $150,001 | Trans-NIH Recovery Act Research Support This is the final report for this award. The project is complete, but the research effort did not exhaust the funds awarded. Closeout documents have been submitted to the National Institute of (fill in) for processing and the remainder of the award is | National Institutes of Health | 1/31/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $150,000 | Trans-NIH Recovery Act Research Support This research project was directed at further studies to identify the natural CD8+ cell anti-HIV factor (CAF). Over the course of the year, we have made substantial progress in evaluating genes that we found to be associated with CAF production. About 3 | National Institutes of Health | 8/13/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $147,546 | Trans-NIH Recovery Act Research Support The studies proposed in the parent grant are generating a resource of gene expression microarray, clinical and morphometric data. The goal of this supplement is to fund a Post-doctoral fellowship in Applied Bioinformatics for analysis of these genomic da | National Institutes of Health | 7/16/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $146,775 | Trans-NIH Recovery Act Research Support The long-term objective of the proposed supplementary work is to characterize how intracellular proteolysis induced in apoptotic cells by cytotoxic drugs and catalyzed by proteases known as caspases, varies as a function of time, cancer cell type, and cyt | National Institutes of Health | 8/30/2010 |
| SUTTER WEST BAY HOSPITALS | $143,564 | Trans-NIH Recovery Act Research Support Our broad research aim is to elucidate the mechanisms through which the basement membrane (BM) directs epithelial architecture and function, and to identify the alterations in cell-BM communications that contribute to cancer progression. Signals resulting | National Institutes of Health | 8/28/2009 |
| FAMILY SERVICE AGENCY OF SAN FRANCISCO | $142,778 | Trans-NIH Recovery Act Research Support To determine cost offset, acceptability & utility of computerized mental health screening & treatment tracking for older, low income mentally ill patients receiving mental health care in community based mental health settings serving diverse populations. | National Institutes of Health | 9/28/2009 |
| ADVANCED GENETIC SYSTEMS INC | $142,313 |
Trans-NIH Recovery Act Research Support DESCRIPTION (provided by applicant): There is a significant need for novel HIV therapies given the emergence of viruses resistant to existing drug regimens. The Rev-RRE protein-RNA interaction in HIV plays an essential role in the transport of viral mRNA
This spending item is part of a $262,313 allocation.
See details
|
National Institutes of Health | 9/15/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $140,901 | Trans-NIH Recovery Act Research Support The parent HPV (Human Papillomavirus) grant for this supplement has resulted in numerous publications and has influenced policy and clinical management strategies which have benefited adolescents and young women. The study has collected over 100,000 speci | National Institutes of Health | 9/22/2009 |
| The J David Gladstone Institutes | $140,000 |
Trans-NIH Recovery Act Research Support To address whether small molecules can be identified that inhibit differentiation of hESCs in the absence of growth factors/cytokines for long-term self-renewal of hESCs (in a way conceptually similar to the function/mechanism of pluripotin in mESCs), we
This spending item is part of a $522,225 allocation.
See details
|
National Institutes of Health | 9/29/2009 |
| BLOOD CENTERS OF THE PACIFIC | $140,000 |
Trans-NIH Recovery Act Research Support This project proposes to initiate a retrospective analysis of the existing biologic specimens to determine if immunosuppressive therapies results in a reduction in the size of the HIV reservoir, as defined by the level of cell-associated RNA and cell-asso
This spending item is part of a $183,177 allocation.
See details
|
National Institutes of Health | 8/30/2010 |
| Economic Opportunity Council of San Francisco, Inc | $135,759 |
ARRA - Head Start This action awards a cost of living adjustment (COLA) increase of 1.84%. This action also awards quality improvement funds for Head Start and for Early Head Start.
This spending item is part of a $774,270 allocation.
See details
|
Administration for Children and Families | 7/01/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $135,591 | Trans-NIH Recovery Act Research Support Biocompatible Dendritic Polymer s for in vivo Application. Overall goal of this research is to devise biodegradable polymer-drug conjugates to improve the treatment of cancer. First goal, to synthesize 100 mg drug equivalent amounts of polymer drugs tha | National Institutes of Health | 8/13/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $135,591 | Trans-NIH Recovery Act Research Support Biocompatible Dendritic Polymers for in vivo Application. Overall goal of this research is to devise biodegradable polymer-drug conjugates to improve the treatment of cancer. First goal, to synthesize 100 mg drug equivalent amounts of polymer drugs that | National Institutes of Health | 8/13/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $134,606 | Trans-NIH Recovery Act Research Support The Multicenter Osteoarthritis Study (MOST) received an NIA ARRA (American Recovery and Reinvestment Act) Administrative Supplement in order to relocate the MOST biospecimens to a reliable commercial repository to facilitate quality assurance for long-ter | National Institutes of Health | 9/11/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $133,006 | Trans-NIH Recovery Act Research Support Eukaryotic cells must ensure that the hundreds to thousands of replication origins in their genomes initiate replication at most once per cell cycle. Failure to prevent re-initiation can cause genetic alteration that might contribute to carcinogenesis. Pr | National Institutes of Health | 12/18/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $131,669 |
Trans-NIH Recovery Act Research Support Atrial fibrillation is the most common clinically significant arrhythmia in adults and one of the most potent risk factors for ischemic stroke and other systemic thromboembolism. It currently affects millions of Americans and its prevalence is expected to
This spending item is part of a $4,971,981 allocation.
See details
|
National Institutes of Health | 9/29/2009 |
| ON24, INC. | $129,382 |
In collaboration with other contractors and staff in HITRC, Lewin will support the RECs in their outreach and marketing of the adoption of EHRs by PHCPs. Lewin has responsibility for identifying the most recent information on marketing HIT adoption in pub
This spending item is part of a $3,288,743 allocation.
See details
|
Agency for Healthcare Research and Quality | 3/31/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $127,193 |
Trans-NIH Recovery Act Research Support On behalf of the Reproductive Medicine Network (RMN), we, as the Data Coordination Center, submit this request in response to NIH announcement NOT-OD-09-056 for a Recovery Act administrative supplement. We will use the supplement to field a comparative ef
This spending item is part of a $7,565,277 allocation.
See details
|
National Institutes of Health | 9/30/2009 |
| NORTHERN CALIFORNIA INSTITUTE FOR RESEARCH AND EDUCATION, INC. | $125,020 | Trans-NIH Recovery Act Research Support With the widespread use of antiretroviral therapy, non-AIDS-related conditions such as cardiovascular disease and chronic kidney disease have emerged as important risk factors for mortality in the aging HIV-infected population. In the United States, cardi | National Institutes of Health | 8/14/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $125,000 | Trans-NIH Recovery Act Research Support Our group specializes in the use of natural plant products as pharmacological probes for exploring nervous system function, especially as this relates to somatosensation (touch and temperature sensation) and pain. The present proposal exploits the use of | National Institutes of Health | 8/14/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $124,914 | Trans-NIH Recovery Act Research Support Immigrant children living in poverty are disproportionately exposed to family, economic, cultural, and community adversities. The autonomic nervous system (ANS) responds to adversities by activating the sympathetic nervous system (flight or fight respons | National Institutes of Health | 9/01/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $123,600 | Trans-NIH Recovery Act Research Support Our laboratory is studying the neural circuitry of the brain. We attempt to generate disease-like states in a model organism, the zebrafish, which can be investigated with genetic methods and microscopy. The long-term goal is to better diagnose and potent | National Institutes of Health | 8/11/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $121,908 | Trans-NIH Recovery Act Research Support The parent grant to this administrative supplement proposal has focused on determining molecular details of the HIV-1 Tat transcription activation mechanism that might lead to new inhibition strategies. Our recent results provide evidence for a unexpected | National Institutes of Health | 5/10/2010 |
| SUTTER WEST BAY HOSPITALS | $121,459 | Trans-NIH Recovery Act Research Support Our primary aim is to assess the association of mtDNA polymorphisms and heteroplasmy with active energy expenditure and resting metabolic rate in the elderly. We will carry out our primary aim in a test of healthy samples from the Health, Aging and Body C | National Institutes of Health | 5/14/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $121,244 | Trans-NIH Recovery Act Research Support As the number of minorities in the population continues to increase, the health disparities for these groups will likely intensify. Underrepresented health care providers are therefore critical to the reduction in these disparities. Programs are thus nee | National Institutes of Health | 7/16/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $120,000 |
Trans-NIH Recovery Act Research Support DESCRIPTION (provided by applicant): There is a significant need for novel HIV therapies given the emergence of viruses resistant to existing drug regimens. The Rev-RRE protein-RNA interaction in HIV plays an essential role in the transport of viral mRNA
This spending item is part of a $262,313 allocation.
See details
|
National Institutes of Health | 9/15/2009 |
| NORTHERN CALIFORNIA INSTITUTE FOR RESEARCH AND EDUCATION, INC. | $119,970 | Trans-NIH Recovery Act Research Support The goal of this proposed administrative supplement grant is to determine risk factors for tumor recurrence after treatment of nonmelanoma skin cancer (NMSC). In particular, data from the NIMSC Cohort Study (funded by the parent grant) will be used to con | National Institutes of Health | 9/18/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $116,828 | Trans-NIH Recovery Act Research Support This research develops methods to study the mechanisms that cells use to distribute signals in order to communicate over short distance and long. These essential mechanisms are involved in processes such as vasculogenesis, neuronal patterning and immune | National Institutes of Health | 12/04/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $115,875 |
Trans-NIH Recovery Act Research Support ARRA Supplement: HIV-Specific T-Cell Responses in Rectal Mucosa. The overall goal of this project is to enhance our understanding of host-virus interactions during chronic infection, with a focus on the immune mechanisms governing control of virus replica
This spending item is part of a $230,688 allocation.
See details
|
National Institutes of Health | 6/07/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $115,719 |
Trans-NIH Recovery Act Research Support Grant Number: Grant Number: 3R01DE016849-04S1 Project Title: DENTIN STRUCTURE, DEMINERALIZATION AND REMINERALIZATION. The ARRA supplement allowed us to hire additional personnel (post-doc or Research Associate) at UCSF to accelerate work on portions of t
This spending item is part of a $175,718 allocation.
See details
|
National Institutes of Health | 9/01/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $115,439 |
Trans-NIH Recovery Act Research Support The Epilepsy Phenome/Genome Project is investigating how genes influence the phenotypes of common and rare epilepsies and has proposed to accelerate collection of phenotypic information by hiring a research assistant at each clinical center.
This spending item is part of a $1,558,189 allocation.
See details
|
National Institutes of Health | 9/25/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $115,345 | Trans-NIH Recovery Act Research Support This grant supplements work on an R01 award on mechanotransduction in fibroblasts to support personnel who will determine how mechanical force promotes actin filament and focal adhesion remodeling in live cells. | National Institutes of Health | 9/30/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $114,330 |
Trans-NIH Recovery Act Research Support The identification of a small subset of HIV-1 infected subjects that exhibit spontaneous control of viral replication (VL<75 copies RNA/mL) in the absence of anti-retroviral therapy (elite controllers) has heightened interest in the mechanism(s) of immune
This spending item is part of a $467,428 allocation.
See details
|
National Institutes of Health | 5/21/2009 |
| SUTTER WEST BAY HOSPITALS | $112,047 |
Trans-NIH Recovery Act Research Support This one-year grant will support planning and protocol development for a 12-month, multi-center randomized trial in which older adults (ages 65 and older) with insomnia will be randomized to one of three treatment arms: 1) Zolpidem (Ambien); 2) Cognitive
This spending item is part of a $176,799 allocation.
See details
|
National Institutes of Health | 9/17/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $111,208 | Trans-NIH Recovery Act Research Support The goal of this project is to identify networks within the brain that are involved in attention and memory and evaluate how these networks may change due to normal aging. Differences in the connectivity and functionality of networks subserving attention | National Institutes of Health | 7/21/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $110,545 |
Trans-NIH Recovery Act Research Support Comparative Effectivenss Research in Pediatric Rheumatic Diseases: Leveraging CA -- The study of childhood rheumatic conditions has been challenged by disease heterogeneity, poor understanding of underlying pathophysiology, small sample sizes, and limit
This spending item is part of a $994,839 allocation.
See details
|
National Institutes of Health | 9/28/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $109,574 | Trans-NIH Recovery Act Research Support The goal is to understand the underpinnings of hormone action as it relates to extracellular fluid volume and electrolyte regulation. This will provide insight into the pathogenesis of hypertension, congestive heart failure and electrolyte disorders. | National Institutes of Health | 9/30/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $108,000 | Trans-NIH Recovery Act Research Support Multidisciplinary Area of Concentration Program in Global Health. The activities for the ARRA supplement include an information and communication technologies (ICT) component to be added to our present University of California San Francisco (UCSF) - Unive | National Institutes of Health | 9/03/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $108,000 | Trans-NIH Recovery Act Research Support ABSTRACT Our hypothesis is that various signaling molecules send information to the nucleus in a tonic fashion to maintain the phenotype of certain developmental stages of thymocytes as well as the stable phenotype of the peripheral T lymphocyte. The bigg | National Institutes of Health | 9/15/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $104,518 |
Trans-NIH Recovery Act Research Support Our primary objective is to identify specific gene variants that are related to the formation and rupture of intracranial aneurysms (IA). Our experienced collaborative and highly productive team of Familial Intracranial Aneurysm (FIA) Investigators at 27
This spending item is part of a $8,081,413 allocation.
See details
|
National Institutes of Health | 9/14/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $104,012 |
Trans-NIH Recovery Act Research Support The current epidemic of Methicillin Resistant Staphylococcus aureus infection is a grand opportunity to apply new genetic methods to understanding this disease. There are multiple outcomes from MRSA infection, ranging from curable localized infection to d
This spending item is part of a $2,000,000 allocation.
See details
|
National Institutes of Health | 9/30/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $103,325 |
Trans-NIH Recovery Act Research Support The goal of this project is to increase recruitment and retention of underrepresented and underserved populations into AIDS Clinical Trials Group (ACTG) clinical trials. The ACTG is committed to enrollment of domestic clinical trial participants in propor
This spending item is part of a $1,130,883 allocation.
See details
|
National Institutes of Health | 9/21/2009 |
| NORTHERN CALIFORNIA INSTITUTE FOR RESEARCH AND EDUCATION, INC. | $103,185 |
Trans-NIH Recovery Act Research Support This project addresses the need to protect active duty personnel and veterans from gonorrhoea. It is the next phase of an on-going program to develop a vaccine against gonococcal infection. This supplement is to add personnel to project tp dp the ELISAs
This spending item is part of a $184,066 allocation.
See details
|
National Institutes of Health | 4/05/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $102,208 | Trans-NIH Recovery Act Research Support The activities of proteins that control cell growth and development must be tightly controlled to prevent the spurious cell proliferation, migration, and resistance to apoptosis that are hallmarks of cancer. Regulation of these proteins is often mediated | National Institutes of Health | 5/29/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $100,000 | Trans-NIH Recovery Act Research Support This administrative supplement is to purchase a Singer RoTorHDA robot equipment specifically designed for high-throughput generic screens in S. cerevisiae. This will accelerate our ability to answer the questions put forth in Aim 3 of the parent grant. | National Institutes of Health | 7/15/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $100,000 | Trans-NIH Recovery Act Research Support The medical application of these studies will be directed to people with diabetes. To date the role of miRNA in islet formation remains unexplored. The studies proposed here may provide new insights with direct application to the production of insulin-pro | National Institutes of Health | 2/25/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $100,000 | Trans-NIH Recovery Act Research Support The objectives of this research plan are to determine the mechanism by which SFA activate PP2A in hepatocytes and the mechanism by which events downstream of PP2A cause lipotoxic cell death. This is the final report for this award. The FFR was submitted | National Institutes of Health | 2/05/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $99,999 | Trans-NIH Recovery Act Research Support Acquisition of an isothermal titration calorimeter to accelerate the tempo of our scientific research to understand neurodegenerative disease caused by human prions, and to find therapies and cures for these fatal diseases. | National Institutes of Health | 9/04/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $99,997 | Trans-NIH Recovery Act Research Support The purchase of a Zeiss Axio Imager M2 motorized microscope will allow applications previously only achievable by confocal microscopy at roughly a third of the comparable cost. This equipment will accelerate our research aimed at understanding the roles o | National Institutes of Health | 12/28/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $99,997 | Trans-NIH Recovery Act Research Support The supplement will identify and localize proteases that are activated in the pancreas and spinal cord during pancreatitis, and will define the role of these proteases in inflammation and pain. It will develop new approaches for non-invasive imaging of | National Institutes of Health | 1/31/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $99,986 | Trans-NIH Recovery Act Research Support This project is to enhance research proposed in the original grant by investigating the persistent and on-going injuries in acutely ACL-injured knees using larger cohort of patients and longer follow up after surgeries using MR T1rho mapping techniques. T | National Institutes of Health | 9/18/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $99,985 | Trans-NIH Recovery Act Research Support This supplement will examine two new mechanisms underlying the trafficking of neurokinin 1 receptor (NK1R) and calcitonin receptor-like receptor/receptor activity modifying protein 1(CLR/RAMP1), which lead to the activation of hypersensitivity to pain in | National Institutes of Health | 12/29/2009 |
| SAN FRANCISCO STATE UNIVERSITY | $99,965 | Trans-NIH Recovery Act Research Support Equipment to improve and increase the capacity for tissue culture instruction for undergraduate MARC & RISE and graduate RISE and Bridge students will use the proposed tissue culture facility/lab. This laboratory would expand and update a current teachin | National Institutes of Health | 8/04/2009 |
| SAN FRANCISCO STATE UNIVERSITY | $99,909 | Trans-NIH Recovery Act Research Support Purchase the equipment and provide supplemental instruction to build skills in reading for comprehension, writing, analyzing and representing scientific data. | National Institutes of Health | 7/31/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $99,844 | Trans-NIH Recovery Act Research Support This is the final report for this award. The project is complete, but the research expense did not exhaust the funds awarded. Closeout documents have been submitted to NCI for processing the remainder of the award that is being returned to NIH. Scanned co | National Institutes of Health | 9/01/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $99,372 | Trans-NIH Recovery Act Research Support This supplement is to purchase a high-tilt and high-resolution cryo-specimen holder equipment and a carbon evaporator equipment to carry out cryoEM experiments proposed in the parent grant. | National Institutes of Health | 9/30/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $98,566 | Trans-NIH Recovery Act Research Support We are studying proteins that prevent inflammation. We have discovered that A20 is a normal protein in all our cells that prevents inflammation. We have found that A20 blocks inflammation by inhibiting activating signals in immune cells. We have also f | National Institutes of Health | 1/20/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $98,350 | Trans-NIH Recovery Act Research Support The scientific relevance of this proposal derives from the potential clarification of the phenotype-genotype relationship within the most common genetic form of severe obesity in humnas. Relevance of the proposal to the intent of the Recovery Act stems fr | National Institutes of Health | 2/16/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $96,938 | Trans-NIH Recovery Act Research Support This grant is for the procurement of an equipment set up for performing electrophysiology studies. This electrophysiology equipment will accelerate the successful completion of the parent grant. | National Institutes of Health | 12/18/2009 |
| SUTTER WEST BAY HOSPITALS | $96,501 |
Trans-NIH Recovery Act Research Support This application entitled, 'Discovering Pathways of Functional Decline: A GWAS Approach' addresses the challenge area (08): Genomics and the specific challenge topic, 08-AG-101: Genetic factors affecting rates of change in disease risk factors with age. T
This spending item is part of a $814,020 allocation.
See details
|
National Institutes of Health | 9/24/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $96,427 |
Trans-NIH Recovery Act Research Support Primary care practice-based research networks (PBRNs) often report high participation rates in their studies. The NIH recognizes PBRNs as important vehicles for translational research projects, strongly supporting them through Clinical and Translational S
This spending item is part of a $1,000,000 allocation.
See details
|
National Institutes of Health | 9/25/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $96,176 | Trans-NIH Recovery Act Research Support Grant name: Novel small-molecule therapies for CF (Supplement). The purpose of this project is to develop and apply a high-throughput screening assay to identify small-molecule inhibitors and disrupters of Pseudomonas biofilms. The goal is to develop a | National Institutes of Health | 9/01/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $94,943 | Trans-NIH Recovery Act Research Support This supplement requests support for an additional method, molecular electron microscopy (EM), to be included in the studies involving all three aims of the prime. | National Institutes of Health | 9/01/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $94,937 | Trans-NIH Recovery Act Research Support Molecular genetics of liver development This administrative supplement is aimed to replace failing equipment used to support our zebrafish colony. PUBLIC HEALTH RELEVANCE It is not known how the endoderm gives rise to the variety of cell types of the dig | National Institutes of Health | 3/08/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $94,603 |
Trans-NIH Recovery Act Research Support Studies are currently underway to examine the genetic factors contributing to a range of addictions, including critical public health problems like smoking and alcohol abuse. New approaches use emerging technologies-such as genome-wide association studies
This spending item is part of a $767,689 allocation.
See details
|
National Institutes of Health | 7/16/2009 |
| SAN FRANCISCO, CITY & COUNTY OF | $93,948 |
Aging Home-Delivered Nutrition Services for States Provides additional funding to Area Agencies on Aging for Elderly Nutrition Home Delivered Meals Programs to feed seniors in need and to restore nutrition services and local food service positions eliminated due to cost increses and funding losses.
This spending item is part of a $3,242,063 allocation.
See details
|
Administration on Aging | 3/18/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $92,975 | Trans-NIH Recovery Act Research Support The ARRA supplement to 5K25CA114254 (5K25CA114254-04S1) was requested to fund activities that would accelerate the progress of the original aims of the parent grant. The focuses of the supplemental funds were identified as 1) hiring of additional staff, 2 | National Institutes of Health | 9/15/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $92,733 |
Trans-NIH Recovery Act Research Support The objective of this project is to create, implement, and evaluate training programs for emerging clinical researchers that blend online and face-to-face instruction to advance health-related research. The aims are to: 1) Develop blended online and face-
This spending item is part of a $522,044 allocation.
See details
|
National Institutes of Health | 9/29/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $92,677 | Trans-NIH Recovery Act Research Support This supplement is expected to accelerate the pace of our research by increasing our rate of participant recruitment, enabling us to reach the sample numbers necessary for the proposed genetic studies sooner. NCE has been awarded for the period 01/01/201 | National Institutes of Health | 1/12/2010 |
| SMITH-KETTLEWELL EYE RESEARCH INSTITUTE, THE | $92,207 | Trans-NIH Recovery Act Research Support The objective of the parent grant is to develop an eye movement model that can predict task-dependent fixation patterns in human observers, and to apply this same model to study eye movement behavior in patients with macular degeneration and other causes | National Institutes of Health | 8/19/2009 |
| NORTHERN CALIFORNIA INSTITUTE FOR RESEARCH AND EDUCATION, INC. | $92,025 | Trans-NIH Recovery Act Research Support We are requesting a 2-year administrative supplement to our R01 (MH058262 Corollary Discharge Dysfunction in Schizophrenia: ERP's and EEG) and the linked K02 (MH067967: Neurobiology of response failure in schizophrenia) grants, which were funded last year | National Institutes of Health | 8/28/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $91,155 | Trans-NIH Recovery Act Research Support The aim of the study is to review donor quality of life, re-read pathology slides from LDLT recipients with HCV or suspected of rejection; re-read postoperative MR & CT scans to assess liver regeneration in donors and recipients - all related to the mai | National Institutes of Health | 2/17/2010 |
| WU YEE CHILDREN'S SERVICES | $90,945 | ARRA - Head Start The Grant funds are used to increase base wages of Early Head Start staff to be competitive to salary within the Head Start field. These funds will allow us to attract and retain BA holders into teaching positions as to meet HS educational and permit mand | Administration for Children and Families | 6/29/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $90,706 | Trans-NIH Recovery Act Research Support The ARRA Administrative Supplement (K08EY018858) supports a parent project that studies The Role of Extracellular Enzymes in Regulating Corneal Repair. The purpose of the project is to investigate the roles of the extracellular enzymes MMP-12 and MMP-8 in | National Institutes of Health | 9/30/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $90,445 |
Trans-NIH Recovery Act Research Support The broad aim of this Grand Opportunity Grant is to understand how race-based social stress, racial/ethnic (R/E) identity, and biological functioning contribute to health and healthy aging. Using the Maryland Adolescent Development in Context Study (MADIC
This spending item is part of a $900,235 allocation.
See details
|
National Institutes of Health | 9/29/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $89,664 |
Trans-NIH Recovery Act Research Support his is an administrative supplement to a funded project focused on accelerating the pace of genetic association studies of Gilles de la Tourette Syndrome (GTS) in population isolates. It is one of three linked applications (together with NS040024 and NS01
This spending item is part of a $250,088 allocation.
See details
|
National Institutes of Health | 9/28/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $89,258 |
Trans-NIH Recovery Act Research Support Specific Aims: Acute Lung Injury (ALI) is a common complication of sepsis and trauma and is associated with mortality of over 20%. Candidate gene studies suggest a role for common genetic variation in determining host susceptibility to ALI in critically
This spending item is part of a $4,676,664 allocation.
See details
|
National Institutes of Health | 9/25/2009 |
| SMITH-KETTLEWELL EYE RESEARCH INSTITUTE, THE | $88,102 |
Trans-NIH Recovery Act Research Support The significant contribution of the Administrative Supplement would be to provide for the long-term hiring of a Research Assistant at UAB which will allow us to increase the rate at which we record using fMRI and electrophysiology in this study. This will
This spending item is part of a $252,134 allocation.
See details
|
National Institutes of Health | 9/30/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $87,832 | Trans-NIH Recovery Act Research Support Purpose This ethnographic study involving up to 30 participants explores patients socio-cultural context at the time of clinical trial (CCT) decision-making to identify how and when the Cancer Information Service can provide appropriate informational supp | National Institutes of Health | 9/17/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $87,546 | Trans-NIH Recovery Act Research Support The DACT1 mouse as a model for OEIS-Purpose: Building on the parent grant, this supplement, which was completed in 2010, supported an additional post-doctoral researcher. Goals: To use a set of specific genetically-engineered mouse lines to explore cross | National Institutes of Health | 9/16/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $87,382 | Trans-NIH Recovery Act Research Support Peripheral arterial disease (PAD) is an understudied debilitating chronic illness that is most prevalent in the elderly. Patients with PAD experience substantial walking impairment, due to symptoms of limb ischemia (claudication) that significantly dimini | National Institutes of Health | 9/01/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $86,980 | Trans-NIH Recovery Act Research Support The aim of the experiments is to identify GPR3 receptor ligands endogenous to ovarian follicles. We have also setup the reconstitution assay to measure GPR3 activation and identified some active molecules that also stimulate oocyte maturation. | National Institutes of Health | 1/08/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $85,598 | Trans-NIH Recovery Act Research Support In this supplement to R01GM070539, almost all of the reactions carried out by cells are done by proteins. When and where these proteins acted is regulated by their destruction. This destruction of these proteins is carried out by a cellular machine the | National Institutes of Health | 1/20/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $84,393 | Trans-NIH Recovery Act Research Support Molecular genetics of pancreas development This administrative supplement is aimed to conduct a chemical screen for small molecules that enhance pancreatic beta-cell neogenesis. PUBLIC HEALTH RELEVANCE: Type 1 diabetes results from the targeted destruct | National Institutes of Health | 4/05/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $83,592 | Trans-NIH Recovery Act Research Support The purpose of this supplement will be to support a part-time data manager and analyst in the United States. This supplement will accelerate the pace of data analysis and publication of results for a project to determine the impact of food insecurity on H | National Institutes of Health | 7/15/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $81,731 | Trans-NIH Recovery Act Research Support In the process of identifying specific genes corresponding to specific candidate loci among large numbers of genes corresponding to broad QTL peaks. | National Institutes of Health | 9/25/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $78,647 | Trans-NIH Recovery Act Research Support Funds were used to purchase equipment and materials used for quantitative measurement of NHE1 activity and microscopic imaging of the localization of NHE1 and NHE1-regulated and -associated proteins in cells. | National Institutes of Health | 8/13/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $78,129 | Trans-NIH Recovery Act Research Support This is an equipment award that will accelerate the studies on a novel model of uveitis and serve the broader community of scientists in the Anderson Lab, the UCSF Diabetes Center, and the Immunology Community. | National Institutes of Health | 8/04/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $77,250 | Trans-NIH Recovery Act Research Support Title: Advancing Islet Transplant for Type 1 Diabetes Care - Islet transplantation in T1D patients with kidney transplants has the potential benefit of treating glycemic instability, allowing maintenance of normoglycemia without the need for insulin thera | National Institutes of Health | 6/21/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $77,250 |
Trans-NIH Recovery Act Research Support Specific Aims: Acute Lung Injury (ALI) is a common complication of sepsis and trauma and is associated with mortality of over 20%. Candidate gene studies suggest a role for common genetic variation in determining host susceptibility to ALI in critically
This spending item is part of a $4,676,664 allocation.
See details
|
National Institutes of Health | 9/25/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $76,146 | Trans-NIH Recovery Act Research Support This project is designed to identify features of the immune response that protect some HIV-exposed persons from infection. The ultimate goal is to apply this knowledge toward the design of an effective vaccine and/or treatement for HIV infection. | National Institutes of Health | 8/30/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $73,843 |
Evidence Based Expert System to assist in treatment of Depression. The purpose of the project is to develop and test computational approaches to one or more cognitive problems as commonly encountered by clinicians, clinical researchers, biologists or pat
This spending item is part of a $377,997 allocation.
See details
|
National Institutes of Health | 9/27/2010 |
| PUBLIC HEALTH FOUNDATION ENTERPRISES, INC. | $73,048 | Trans-NIH Recovery Act Research Support The San Francisco Vaccine and Prevention Unit (SFVPU) provides scientific leadership, capacity to recruit study volunteers into vaccine and non-vaccine prevention trials, innovative methods for community engagement in research, and mentorship of junior in | National Institutes of Health | 6/03/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $71,178 | Trans-NIH Recovery Act Research Support This supplement stimulated employment and accelerated investigation into the characterization of the bacterial actin-like protein, ParM. ParM-dependent DNA segregation helps us understand how cytoskeletal ploymers organize. | National Institutes of Health | 9/30/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $70,908 | Trans-NIH Recovery Act Research Support The UCSF Biomedical Sciences Program is an interdisciplinary predoctoral graduate research program that equips students with the training and research tools to study the function of tissue and organ systems in development, physiology, and disease. | National Institutes of Health | 8/13/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $69,162 | Trans-NIH Recovery Act Research Support The kidney, like many epithelial organs, consists mainly of tubules lined by a monolayer of polarized epithelial cells. Though we have learned a great deal about the genes that control kidney development, we know much less about the mechanisms by which c | National Institutes of Health | 12/21/2009 |
| BLOOD CENTERS OF THE PACIFIC | $67,614 |
Trans-NIH Recovery Act Research Support The Impact of Early Antiretroviral Therapy in HIV Persistence grant aims to determine the effect of early versus delayed HAART on viral persistence, and to determine the association between high-through put measures of low level viral load and amount of r
This spending item is part of a $1,408,606 allocation.
See details
|
National Institutes of Health | 9/25/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $67,025 |
Trans-NIH Recovery Act Research Support The Fogarty International Clinical Research Scholars & Fellows Support Center @ Vanderbilt University G?? Association of American Medical Colleges (FICRS?F) requests an administrative increase for the Fogarty International Clinical Research Scholars Suppo
This spending item is part of a $3,000,000 allocation.
See details
|
National Institutes of Health | 6/20/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $67,025 |
Trans-NIH Recovery Act Research Support The Fogarty International Clinical Research Scholars & Fellows Support Center @ Vanderbilt University G?? Association of American Medical Colleges (FICRS?F) requests an administrative increase for the Fogarty International Clinical Research Scholars Suppo
This spending item is part of a $3,000,000 allocation.
See details
|
National Institutes of Health | 6/20/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $66,764 | Trans-NIH Recovery Act Research Support GRANT NAME: SCOR on Lower Urinary Tract Function in Women AWARD DESCRIPTION: Purpose This study is designed to assess whether markers of oxidative stress are associated with incontinence in patients with type 2 diabetes and to test the hypothesis that | National Institutes of Health | 9/29/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $64,867 |
Trans-NIH Recovery Act Research Support Traditional frequentist methods for analysis of clinical trials are generally accepted as the gold standard in research practice. Newer Bayesian methods, however, hold great promise for a more efficient analytic approach, thereby lowering the costs of cl
This spending item is part of a $937,264 allocation.
See details
|
National Institutes of Health | 9/20/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $60,255 | Trans-NIH Recovery Act Research Support Create an easily modifiable Prenatal Testing Program which will reflect changes in the State of California's Prenatal Screening Program and will be used in our ongoing study of an informed free choice approach to prenatal screening of chrom. disorders. | National Institutes of Health | 9/22/2009 |
| Allison & Partners Los Angeles Inc | $60,000 |
ARRA - Prevention and Wellness--State Territories and Pacific Islands The California Department of Public Health (CDPH) proposes to promote wellness and reduce chronic disease through statewide and local initatives in the areas of nutrition, physical activity, and tobacco use. CDPH proposes to educacate about the benefits of ... Show more
This spending item is part of a $2,200,000 allocation.
See details
|
Centers for Disease Control and Prevention | 2/06/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $59,182 | Trans-NIH Recovery Act Research Support This is a study of the mutational analysis of E. Coli core RNA polymerase. | National Institutes of Health | 8/03/2009 |
| APERYS | $58,062 | Trans-NIH Recovery Act Research Support Administrative supplement for High-Resolution Patterning of Neuron Cultures to Enable High-Throughput Assays Neuronal cell culture is a cornerstone of neuroscience research and is used extensively in studies of brain and behavior. The in vitro environment | National Institutes of Health | 9/15/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $56,920 | Trans-NIH Recovery Act Research Support This supplement provided critical salary support for two senior postdoctoral fellows, and allowed them to continue employment in the Vale lab and make transitions to full-time positions. | National Institutes of Health | 9/30/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $55,527 | Trans-NIH Recovery Act Research Support To purchase a Spectramax M5 Microplate Reader, which is a dual-monochromator, multi-detection microplate reader with the detection modalities. The optics on this plate reader are comparable to a state-of-the-art cuvette fluorometer. | National Institutes of Health | 9/18/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $54,200 | Trans-NIH Recovery Act Research Support he project will establish an independent unit and will ensure it is appropriately staffed, trained, and resourced within the Institute to oversee the ethical review process at KEMRI. To achieve this, we will pilot the implementation of a multi-committee m | National Institutes of Health | 9/25/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $54,036 | Trans-NIH Recovery Act Research Support Title: Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients - To be utilized to help fund series of investigator meeting to be held during the course of the parent grant. The meetings will be attended by PI, Co-PI and critical per | National Institutes of Health | 5/05/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $54,000 | Trans-NIH Recovery Act Research Support This is a supplement to parent grant K23DK077734 to increase the hours of the research coordinator. The increased hours allowed the coordinator to extend clinic sessions, enrolled more patients, etc. All funding was spent as of last quarter. The parent | National Institutes of Health | 8/24/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $54,000 | Trans-NIH Recovery Act Research Support The ARRA supplement award Improving Biomaterials from a Cellular Point of Views is to increase the productivity by carrying out additional experiments needed to test the objectives of the parent grant. Specifically we and others have shown that ions rele | National Institutes of Health | 9/22/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $54,000 | Trans-NIH Recovery Act Research Support This is the final report for this award. The project is complete, but the research effort did not exhaust the funds awarded. Closeout documents have been submitted to the NIH NINDS for processing and the remainder of the award is being returned to the NIH | National Institutes of Health | 8/17/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $54,000 | Trans-NIH Recovery Act Research Support Grant Name: Obesity and Urinary Incontinence (OUI) To explore a novel treatment for urinary incontinence, mindfulness-based weight loss, and investigate possible mechanisms of the treatment effect of weight loss on urinary incontinence a randomized cli | National Institutes of Health | 9/29/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $54,000 | Trans-NIH Recovery Act Research Support PI left UCSF as of 10/31/09. Project has filed for early termination. | National Institutes of Health | 9/15/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $54,000 | Trans-NIH Recovery Act Research Support This is a study of molecular mechanisms involved in GILZ regulation that appears to dictate the activity state of ENaC, an ion channel that critically controls blood pressure. | National Institutes of Health | 12/21/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $54,000 | Trans-NIH Recovery Act Research Support Use shRNA techniques to understand the role of the nectin signaling pathway in apoptosis and obstructive nephropathy. Evaluate polarity during organ development in kidney and lung using real-time microscopy of organs in culture. | National Institutes of Health | 12/18/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $54,000 | Trans-NIH Recovery Act Research Support In the current proposal, we will incorporate recently published data and results presented at the Conference of Retroviruses and Opportunistic Infections to guide our investigation of inflammation in the host. | National Institutes of Health | 12/17/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $54,000 | Trans-NIH Recovery Act Research Support To determine whether maintenance of T-regs in gut tissue is associated with maintenance of Th17 cell function and, if so, to test whether Th17 cell function offers a superior explanation for variations in T cell activation. | National Institutes of Health | 8/02/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $53,901 | Trans-NIH Recovery Act Research Support To better understand how MEK is regulated, novel techniques will be used to perform biochemical studies in primary stem and progenitor cells. | National Institutes of Health | 9/14/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $51,925 | Trans-NIH Recovery Act Research Support This award provides funds to accelerate the tempo of my scientific research on the role of the microglia/macrophage response in brain tumor progression and invasion; it allows me to hire a full-time technician and procure needed resources and equipment. | National Institutes of Health | 9/24/2009 |
| WESTED | $51,750 |
The goal of this procurement is to develop a new measure to assess the quality of child care settings, specifically the quality of caregiver-child interaction for infants and toddlers in non-parental care. The new measure should be appropriate for use acr
This spending item is part of a $4,061,923 allocation.
See details
|
Program Support Center | 9/30/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $50,000 | Trans-NIH Recovery Act Research Support This research project will help accelerate the pace of scientific discovery for a patient-oriented clinical research program on novel diagnostics for HIV-associated tuberculosis (TB). | National Institutes of Health | 6/01/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $50,000 | Trans-NIH Recovery Act Research Support The title of this award is Oral Wash for Nucleic Acid Diagnosis and Prognosis of TB (Tuberculosis). This research project will help accelerate the pace of scientific discovery for a patient-oriented clinical research program on novel diagnostics for HIV | National Institutes of Health | 9/11/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $49,999 | Trans-NIH Recovery Act Research Support Cancer Center Support Grant - The ADOPTion of New Technologies for Remote Data Capture and Protocol Authoring is intended to improve the efficiency and effectiveness of the clinical trials process and reduce costs, thereby realizing the goal of more rapid | National Institutes of Health | 9/17/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $49,770 | Trans-NIH Recovery Act Research Support The project examines the relationship between gastroesophageal reflux and erosive tooth injury. 80 subjects are presently enrolled and will be organized into a databse for analysis, as well as brought in for follow-up. | National Institutes of Health | 8/31/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $49,195 | Trans-NIH Recovery Act Research Support The project established magnetic resonance based physiologic biomarkers of malignant progression of glial tumors to improve noninvasive monitoring of patients with glioma | National Institutes of Health | 9/29/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $49,139 | Trans-NIH Recovery Act Research Support This project will accelerate and augment the studies proposed in Aim 3 of the parent grant application. We will initiate an immediate analysis of T-reg populations and Th17 cell function within existing HIV+ gut biopsy specimens. | National Institutes of Health | 9/11/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $49,139 | Trans-NIH Recovery Act Research Support The title of this award is Regulatory T cell influence on infant and adult immune responses to HIV. This project will accelerate and augment the studies proposed in Aim 3 of the parent grant application. We will initiate an immediate analysis of T-reg p | National Institutes of Health | 9/11/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $48,598 | Trans-NIH Recovery Act Research Support This is a supplement to a K23 project entitled Impact of HIV on the T cell repertoire. The parent project is a cross-sectional study of the effect of HIV infection on T cell diversity. Loss of T cell diversity is thought to play an important role in the | National Institutes of Health | 8/02/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $48,026 | Trans-NIH Recovery Act Research Support This supplement to a K23 award funds the analysis of lymphocyte samples with the AmpliCot assay to measure T lymphocyte diversity. We are testing the hypothesis that HIV immunodeficiency is due to holes in the T cell receptor repertoire. | National Institutes of Health | 9/21/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $46,537 | Trans-NIH Recovery Act Research Support We will characterize the structure and function of Vomp adhesins of the human pathogen Bartonella quintana to better understand how this emerging pathogen causes disease in humans and identify novel strategies to combat B. quintana infection. | National Institutes of Health | 7/17/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $45,999 |
Trans-NIH Recovery Act Research Support This supplemental award supports the Accelerating Clinical Trials of Novel Oncologic Path Ways (ACTNOW) program for Protocol ANBL0931, which is a Phase III Study of Chimeric Antibody 14.18 in High-Risk Neuroblastoma. The primary objective of study ANBL09
This spending item is part of a $1,981,588 allocation.
See details
|
National Institutes of Health | 8/07/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $43,177 |
Trans-NIH Recovery Act Research Support This project proposes to initiate a retrospective analysis of the existing biologic specimens to determine if immunosuppressive therapies results in a reduction in the size of the HIV reservoir, as defined by the level of cell-associated RNA and cell-asso
This spending item is part of a $183,177 allocation.
See details
|
National Institutes of Health | 8/30/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $42,500 | Trans-NIH Recovery Act Research Support purchase a Real-Time q-PRC instrument to validate ATR targets and the knock-down of si-RNA | National Institutes of Health | 8/13/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $42,390 | Trans-NIH Recovery Act Research Support Vi-CELL-? Cell Viability Analyzer provides an automatic way to determine cell concentration and viability based on trypan blue dye exclusion. It provides a cost effective and time saving way to increase accuracy and decrease variability due to human error | National Institutes of Health | 8/02/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $40,104 | Trans-NIH Recovery Act Research Support The goal of this administrative supplement is to increase the researcher's effort to directly enhance and accelerate the aims of the parent grant in both cultured cell lines and in mouse model systems and to provide supplemental funds to purchase equipmen | National Institutes of Health | 1/26/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $38,625 | Trans-NIH Recovery Act Research Support This project uses zebrafish genetics to understand the molecular and cellular mechanisms underlying the biological effect of ethanol in vivo. | National Institutes of Health | 7/31/2009 |
| SAN FRANCISCO STATE UNIVERSITY | $38,555 | Trans-NIH Recovery Act Research Support This supplement will accelerate the pace of research that examines the physiological and genetic responses to osmotic stress in yeast.-? This ARRA supplement provides for increased employment of a research assistant from part-time (30 hr/wk) to full time | National Institutes of Health | 8/20/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $37,046 |
Trans-NIH Recovery Act Research Support To date, one must conclude that the pace of progress in disease control and preservation of functional integrity and quality of life for pediatric brain tumors remains below that of most other major types of childhood cancers. Recent advances in cellular
This spending item is part of a $381,202 allocation.
See details
|
National Institutes of Health | 8/20/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $36,696 |
Trans-NIH Recovery Act Research Support To date, one must conclude that the pace of progress in disease control and preservation of functional integrity and quality of life for pediatric brain tumors remains below that of most other major types of childhood cancers. Recent advances in cellular
This spending item is part of a $482,421 allocation.
See details
|
National Institutes of Health | 8/18/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $36,696 |
Trans-NIH Recovery Act Research Support To date, one must conclude that the pace of progress in disease control and preservation of functional integrity and quality of life for pediatric brain tumors remains below that of most other major types of childhood cancers. Recent advances in cellular
This spending item is part of a $482,434 allocation.
See details
|
National Institutes of Health | 8/19/2009 |
| NORTHERN CALIFORNIA INSTITUTE FOR RESEARCH AND EDUCATION, INC. | $36,012 |
Trans-NIH Recovery Act Research Support The overarching goal of the Function BIRN (FBIRN) is to develop technology and methods to conduct multi- site functional imaging studies, and to produce a knowledge base that would not otherwise be available through single-site imaging studies. The techno
This spending item is part of a $926,175 allocation.
See details
|
National Institutes of Health | 9/28/2009 |
| SUTTER WEST BAY HOSPITALS | $35,622 | Trans-NIH Recovery Act Research Support Project Summary A) Scope of the overall project and the anticipated contribution of the requested supplement. I requested to increase the hours of our current part-time staff to full-time in 2010. The requested supplement will be used as outlined in Sp | National Institutes of Health | 9/17/2009 |
| INTERNATIONAL INSTITUTE OF THE BAY AREA, THE | $35,000 |
Trans-NIH Recovery Act Research Support We propose to expand the recruitment for the Epidemiology of H. pylori transmission to a second county facility in the Bay Area. Currently, we are recruiting predominantly at the refugee and, to a lesser degree, at the immunization clinic at Santa Clara
This spending item is part of a $175,952 allocation.
See details
|
National Institutes of Health | 7/12/2010 |
| SAN FRANCISCO STATE UNIVERSITY | $34,664 | Trans-NIH Recovery Act Research Support This research will elucidate the molecular activities of key proteins used by related bacteria for survival in the environment and infection of their hosts.-? This research is an administrative supplement to the parent grant to fund 1)-?acquisition of a n | National Institutes of Health | 7/30/2010 |
| SAN FRANCISCO STATE UNIVERSITY | $34,086 |
Trans-NIH Recovery Act Research Support Childhood cancer survivors represent a large and growing group of survivors who are at increased risk for developing subsequent cancers. Therefore, it is of critical importance that all preventable risk factors be minimized among this population. We have
This spending item is part of a $47,282 allocation.
See details
|
National Institutes of Health | 6/04/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $33,857 | Trans-NIH Recovery Act Research Support While health communication plays a critical role in reducing health disparities there are no existing best practice standards for how health information should be disseminated to Chinese Americans. The purpose of this administrative supplement is to explo | National Institutes of Health | 5/20/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $33,717 | Trans-NIH Recovery Act Research Support This study will compare the effects of 24 months of a multiple risk factor reduction program vs enhanced standard care on walking distance and endothelial function in PAD patients. Note: A relinquishing statement has been submitted to NIH with an early en | National Institutes of Health | 5/13/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $33,482 | Trans-NIH Recovery Act Research Support Title: Living Donor Liver Transplant: Short & Long-Term Impact on Donors and Recipients - Funds provided to purchase an instrumentation and flow probes to perform the intra-operative measurements of blood flow to the liver vessels in the normal donors and | National Institutes of Health | 9/30/2010 |
| SPLUNK INC. | $33,360 | Splunk Enterprise Perpetual License and Splunk for PCI Perpetual, 5 GB/day | Program Support Center | 10/01/2009 |
| WU YEE CHILDREN'S SERVICES | $33,334 |
ARRA Child Care and Development Block Grant Title: ARRA Supplemental Funding for Child Care and Development Fund (CCDF); Description: Provide child care financial assistance to low-income working families and fund activities to improve the quality of child care.
This spending item is part of a $220,273,864 allocation.
See details
|
Administration for Children and Families | 4/09/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $33,313 | We have/are in the process of completed(ing) the Material transfer Agreement and Data Use Agreement with the TCGA Biospecimen Core Resources. Moreover, we have received (submitted for) Institutional Review Board approval for participation in TCGA. Durin | National Institutes of Health | 4/21/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $32,558 | Trans-NIH Recovery Act Research Support The goal of the project is to understand the inherent characteristics of tissues and their interfaces involved in tooth attachment, such that they can be mimicked in long-term goal of functional tissue regeneration. | National Institutes of Health | 9/22/2009 |
| Whitney Young Child Dev Ctr | $30,467 |
ARRA Child Care and Development Block Grant Title: ARRA Supplemental Funding for Child Care and Development Fund (CCDF); Description: Provide child care financial assistance to low-income working families and fund activities to improve the quality of child care.
This spending item is part of a $220,273,864 allocation.
See details
|
Administration for Children and Families | 4/09/2009 |
| PACIFIC NEWS SERVICE | $30,394 |
In support of the National Center for Immunization and Respiratory Diseases' (NCIRD) aim to promote immunization throughout the lifespan, AED will apply communication and social marketing and risk communication research, theories, principles, and practice
This spending item is part of a $4,450,426 allocation.
See details
|
Centers for Disease Control and Prevention | 9/30/2010 |
| PUBLIC POLICY INSTITUTE OF CALIFORNIA | $29,872 |
Trans-NIH Recovery Act Research Support This project examines the effects of state child safety seat laws for children aged 4-9 on 1) children being restrained in child safety seats, and 2) child fatalities and injuries. We combine three publicly-available date sets to examine these issues at t
This spending item is part of a $168,586 allocation.
See details
|
National Institutes of Health | 9/24/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $28,960 |
Trans-NIH Recovery Act Research Support This award supports the therapeutic work for childhood Acute Lymphoblastic Leukemia (ALL), which is the most common childhood cancer and is a leading cause of cancer-related death. This project is designed to 1) validate the key TARGET (Therapeutically A
This spending item is part of a $1,708,950 allocation.
See details
|
National Institutes of Health | 9/29/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $28,355 |
Trans-NIH Recovery Act Research Support North American AIDS Cohorts Collaboration on Research and Design A disturbing increase in the incidence of non-AIDS-defining conditions including renal disease, metabolic and cardiovascular disease, and malignancies has been observed in recent years, and
This spending item is part of a $7,312,062 allocation.
See details
|
National Institutes of Health | 9/21/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $27,580 |
Trans-NIH Recovery Act Research Support This award supports the therapeutic work for childhood Acute Lymphoblastic Leukemia (ALL), which is the most common childhood cancer and is a leading cause of cancer-related death. This project is designed to 1) validate the key TARGET (Therapeutically A
This spending item is part of a $1,708,950 allocation.
See details
|
National Institutes of Health | 9/29/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $27,000 | Trans-NIH Recovery Act Research Support This award provided research to study carbohydrate receptors (AIM1) on the surface of the murine oral cavity to determine the various carbohydrate sultotransfererases expression as well as the effect of the estrogen and/or progesterone on enzymes (AIM3) | National Institutes of Health | 9/22/2009 |
| J.DAVID GLADSTONE INSTITUTES, THE | $26,243 | Trans-NIH Recovery Act Research Support We propose to create a flexible polycistronic system for expressing multiple engineered receptors to facilitate the engineering of tissues, such as cardiac cells, brain, and bone. We developed new class of G-protein- coupled receptors (GPCRs) that are cal | National Institutes of Health | 6/04/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $25,259 | Trans-NIH Recovery Act Research Support The study of the developmental regulation of tooth number and shape is important for understanding both human disease and evolutionary biology. Mammalian tooth development is controlled by signaling between the oral epithelium and the neural crest-derived | National Institutes of Health | 9/22/2009 |
| UNIVERSITY OF SAN FRANCISCO INC | $23,943 | ARRA - Scholarships for Disadvantaged Students ARRA-Scholarship for Disadvantaged Students. Scholarship awarded to disadvantaged nursing students | Health Resources and Services Administration | 9/03/2009 |
| CITY & COUNTY OF SAN FRANCISCO | $23,247 |
Trans-NIH Recovery Act Research Support Purpose: The aim of the HEARTS study is to better understand the distribution and correlates of Human Papilloma Virus (HPV) among homeless and unstably housed women. Goal: The overall goal of the study is to provide population-specific inform for pre
This spending item is part of a $345,003 allocation.
See details
|
National Institutes of Health | 8/11/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $23,234 | Trans-NIH Recovery Act Research Support To study the effector function of natural killer T (NKT) cells in sarcoidosis. | National Institutes of Health | 6/04/2009 |
| J.DAVID GLADSTONE INSTITUTES, THE | $21,931 | Trans-NIH Recovery Act Research Support TDP-43 is a major pathological protein in amyotrophic lateral sclerosis (ALS) and some forms of frontotemporal dementia (FTD) and is also present in ubiquitinated inclusions seen in other neurodegenerative diseases. How TDP-43 contributes to age-dependent | National Institutes of Health | 9/25/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $20,016 |
Trans-NIH Recovery Act Research Support The goal of the parent grant is to identify retained solutes that are associated with poor outcomes in hemodialysis patients. The study design is a cohort study in which biological specimens have been obtained and stored. This supplement request would e
This spending item is part of a $100,425 allocation.
See details
|
National Institutes of Health | 8/09/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $20,000 |
Trans-NIH Recovery Act Research Support Chronic kidney disease (CKD) in children is a devastating illness. The prevalence of patients aged 0 ? 19 years with ESRD has grown 32% since 1990 and the mortality rate for children with ESRD receiving dialysis therapy is between 30 and 150 times that o
This spending item is part of a $525,000 allocation.
See details
|
National Institutes of Health | 9/27/2009 |
| NORTHERN CALIFORNIA INSTITUTE FOR RESEARCH AND EDUCATION, INC. | $17,980 | Trans-NIH Recovery Act Research Support An intact alveolar epithelial barrier is required for recovery from acute lung injury and ARDS, but the mechanisms for regulation of the alveolar barrier are not fully understood. Previous work in our laboratory has shown that the tight junction protein c | National Institutes of Health | 5/30/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $17,394 | Trans-NIH Recovery Act Research Support Alcohol use disorders (AUDs) are a major problem in medicine and society, and the few available treatment strategies have so far met with limited success. It is well established that genetic, psychosocial, and environmental factors contribute to an increa | National Institutes of Health | 8/09/2010 |
| SMITH-KETTLEWELL EYE RESEARCH INSTITUTE, THE | $16,656 | Trans-NIH Recovery Act Research Support This project uses a novel neuro-imaging technique to examine the flow of disparity information from V1 to extrastriate areas in human cortex. It relies on complex analytical techniques to localize the likely sources that generate the scalp potentials re | National Institutes of Health | 7/17/2009 |
| SAN FRANCISCO STATE UNIVERSITY | $16,242 |
ARRA Child Care and Development Block Grant Title: ARRA Supplemental Funding for Child Care and Development Fund (CCDF); Description: Provide child care financial assistance to low-income working families and fund activities to improve the quality of child care.
This spending item is part of a $220,273,864 allocation.
See details
|
Administration for Children and Families | 4/09/2009 |
| J.DAVID GLADSTONE INSTITUTES, THE | $15,796 | Trans-NIH Recovery Act Research Support Frontotemporal dementia (FTD), the second most common form of age-dependent dementia, is associated with focal degeneration of the frontal and temporal lobes. This insidious disorder is distinct from Alzheimer's disease (AD). For instance, recent studies | National Institutes of Health | 9/15/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $15,000 | Trans-NIH Recovery Act Research Support This grant funds the procurement of a Chromatography equipment set up to supplement parent grant number 1K08HD058599-01 | National Institutes of Health | 2/25/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $15,000 | Trans-NIH Recovery Act Research Support This award will fund the purchase of a pump, gradient mixer, UV detector, and fraction collector to perform chromatography. The purchase of dedicated equipment for this purpose will allow accurate, reproducible and optimizable purification conditions by | National Institutes of Health | 2/25/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $13,133 | Trans-NIH Recovery Act Research Support This study addresses the growth of PC12 cells in vitro and observation of neurite grown after infecting the cells with HSV mutant strains. This project was completed during summer 2009. | National Institutes of Health | 7/14/2009 |
| UNIVERSITY OF SAN FRANCISCO INC | $10,852 | ARRA - Scholarships for Disadvantaged Students ARRA-Scholarships for Disadvantaged Students. Scholarship awarded to disadvantaged nursing students. | Health Resources and Services Administration | 6/14/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $10,460 |
Trans-NIH Recovery Act Research Support The funds will be used to develop, open and analyze three H1N1 studies in HIV-infected populations. The first study will determine the safety and immunogenicity of an H1N1 vaccine in HIV-infected pregnant women. The second study will determine safety an
This spending item is part of a $1,701,287 allocation.
See details
|
National Institutes of Health | 11/25/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $8,980 |
Trans-NIH Recovery Act Research Support The funds will be used to develop, open and analyze three H1N1 studies in HIV-infected populations. The first study will determine the safety and immunogenicity of an H1N1 vaccine in HIV-infected pregnant women. The second study will determine safety an
This spending item is part of a $1,701,287 allocation.
See details
|
National Institutes of Health | 11/25/2009 |
| SUTTER WEST BAY HOSPITALS | $7,738 | Trans-NIH Recovery Act Research Support Th.e Scope of Work for the project remains essentially unchanged. There will still be 3 Specific Aims: Specific Aim 1 G?? Optimize SFHR frequency by testing different sizes and types (single versus double stranded) of fragment, Specific Aim 2 G??Determin | National Institutes of Health | 4/30/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $7,425 |
Trans-NIH Recovery Act Research Support Grant Name: Understanding Smokeless Tobacco Marketing n The goal of the parent grant is to gain a better understanding of smokeless tobacco (SLT) marketing strategies and how these impact use, particularly SLT uptake by new users and smoking cessation am
This spending item is part of a $155,937 allocation.
See details
|
National Institutes of Health | 9/02/2010 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $7,264 | Trans-NIH Recovery Act Research Support The proposed studies will further elucidate mechanisms of matrix protein self-assembly in enamel and as such provide important information for understanding enamel formation on the molecular and nanometer scale. | National Institutes of Health | 6/02/2009 |
| NOVATO YOUTH CENTER | $5,867 |
ARRA Child Care and Development Block Grant Title: ARRA Supplemental Funding for Child Care and Development Fund (CCDF); Description: Provide child care financial assistance to low-income working families and fund activities to improve the quality of child care.
This spending item is part of a $220,273,864 allocation.
See details
|
Administration for Children and Families | 4/09/2009 |
| Holy Family Day Homes | $3,928 |
ARRA Child Care and Development Block Grant Title: ARRA Supplemental Funding for Child Care and Development Fund (CCDF); Description: Provide child care financial assistance to low-income working families and fund activities to improve the quality of child care.
This spending item is part of a $220,273,864 allocation.
See details
|
Administration for Children and Families | 4/09/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $2,196 |
Trans-NIH Recovery Act Research Support The funds will be used to develop, open and analyze three H1N1 studies in HIV-infected populations. The first study will determine the safety and immunogenicity of an H1N1 vaccine in HIV-infected pregnant women. The second study will determine safety an
This spending item is part of a $1,701,287 allocation.
See details
|
National Institutes of Health | 11/25/2009 |
| POMEROY, JANET CENTER, THE | $1,611 |
ARRA Child Care and Development Block Grant Title: ARRA Supplemental Funding for Child Care and Development Fund (CCDF); Description: Provide child care financial assistance to low-income working families and fund activities to improve the quality of child care.
This spending item is part of a $220,273,864 allocation.
See details
|
Administration for Children and Families | 4/09/2009 |
| NORTHERN CALIFORNIA INSTITUTE FOR RESEARCH AND EDUCATION, INC. | $1,500 |
Trans-NIH Recovery Act Research Support Project Title: A Six-Month, RCT of Probuphine Safety and Efficacy in Opioid Addiction. We are conducting a six-month, randomized, placebo and active-controlled, multicenter clinical trial of Probuphine in patients with opioid dependence for the purpose
This spending item is part of a $7,586,848 allocation.
See details
|
National Institutes of Health | 9/30/2009 |
| NORTH EAST MEDICAL SERVICES | $1,000 |
The Office of Statewide Health Planning and Development (OSHPD), working collaboratively with the California Primary Care Association (CPCA) and the California Area Health Education Center (AHEC) will administer California's first HRSA/NHSC Cal-SE
This spending item is part of a $579,000 allocation.
See details
|
Health Resources and Services Administration | 9/30/2009 |
| NORTH EAST MEDICAL SERVICES | $1,000 |
The Office of Statewide Health Planning and Development (OSHPD), working collaboratively with the California Primary Care Association (CPCA) and the California Area Health Education Center (AHEC) will administer California's first HRSA/NHSC Cal-SE
This spending item is part of a $579,000 allocation.
See details
|
Health Resources and Services Administration | 9/30/2009 |
| NORTH EAST MEDICAL SERVICES | $1,000 |
The Office of Statewide Health Planning and Development (OSHPD), working collaboratively with the California Primary Care Association (CPCA) and the California Area Health Education Center (AHEC) will administer California's first HRSA/NHSC Cal-SEARCH pro
This spending item is part of a $579,000 allocation.
See details
|
Health Resources and Services Administration | 9/30/2009 |
| NORTH EAST MEDICAL SERVICES | $1,000 |
The Office of Statewide Health Planning and Development (OSHPD), working collaboratively with the California Primary Care Association (CPCA) and the California Area Health Education Center (AHEC) will administer California's first HRSA/NHSC Cal-SEARCH pro
This spending item is part of a $579,000 allocation.
See details
|
Health Resources and Services Administration | 9/30/2009 |
| SAN FRANCISCO UNIFIED SCHOOL DISTRICT | $360 |
ARRA Child Care and Development Block Grant Title: ARRA Supplemental Funding for Child Care and Development Fund (CCDF); Description: Provide child care financial assistance to low-income working families and fund activities to improve the quality of child care.
This spending item is part of a $220,273,864 allocation.
See details
|
Administration for Children and Families | 4/09/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $0 |
Trans-NIH Recovery Act Research Support To determine cost offset, acceptability & utility of computerized mental health screening & treatment tracking for older, low income mentally ill patients receiving mental health care in community based mental health settings serving diverse populations.
This spending item is part of a $142,777 allocation.
See details
|
National Institutes of Health | 9/28/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $0 | Trans-NIH Recovery Act Research Support This award was relinquished prior to the start of the project. | National Institutes of Health | 9/11/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $0 |
Trans-NIH Recovery Act Research Support The title of this award is Primary Immune Deficiency Treatment Consortium (PIDTC). Primary immune deficiencies (PIDs) are rare, life-threatening inherited defects in the immune system. Specific goals are to characterize the long term outcomes and late ef
This spending item is part of a $2,483,108 allocation.
See details
|
National Institutes of Health | 9/11/2009 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | $0 |
ARRA Grants for Training in Primary Care Medicine and Dentistry Training and Enhancement Grant Name: Clinical Care of the Underserved Purpose: Our project's purpose is to train students to provide primary care for vulnerable patient populations and support career interests in working with underserveded communities. Project Goals: Our first ob... Show more
This spending item is part of a $261,485 allocation.
See details
|
Health Resources and Services Administration | 7/15/2010 |